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ABSTRACT
NURSES’ USE OF HAZARDOUS DRUG SAFE HANDLING PRECAUTIONS
by
MARTHA POLOVICH
Problem: Nurses are potentially exposed to hazardous drugs (HDs) in their practice. HD
exposure is associated with adverse outcomes (reproductive problems, learning
disabilities in offspring of nurses exposed during pregnancy, and cancer occurrence).
Safe handling precautions (safety equipment and personal protective equipment, [PPE])
minimize exposure to HDs and decrease the potential for adverse outcomes. Despite
existing OSHA recommendations, adherence to precautions is below recommendations.
The purpose of this study was to examine relationships among factors affecting nurses’
use of HD safe handling precautions, to identify factors that promote or interfere with HD
precaution use, and to determine nurse managers’ perspectives on use of safe handling
precautions. This study used a conceptual model which proposes that both individual and
organizational factors influence precaution use.
Methods: A cross-sectional, correlational design was used. Nurses (N = 165; 46%
response rate) from oncology centers across the US who reported handling chemotherapy
completed a mailed survey. Instruments measured HD precaution use, knowledge, self
efficacy, barriers, perceived risk, conflict of interest, interpersonal influences and
workplace safety climate. Hierarchical regression was used. Twenty managers of nurses
handling chemotherapy were interviewed.
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Results: Nurses were experienced in oncology (M = 15.8 ± 7.6) yrs, well-educated
(62.5% ≥BSN), certified in oncology nursing (85%), worked in outpatient settings (69%),
and on average treated 6.8 ± 5.2 patients per day. Chemotherapy exposure knowledge
was high (M = 10.9, ± 1, 0-12 scale); as was self efficacy for using PPE (M = 20.8 ± 3, 724 scale), and perceived risk (M = 3.14 ± .6, 0-4 scale). Total precaution use during HD
administration and disposal was low (M = 1.9, SD = 1.1, 0= never to 5 = 100%). Nurse
characteristics did not predict HD precaution use. In the final model (R2 = .29, F (2, 155)
= 24.6, p < .000), fewer patients per day, fewer barriers and better workplace safety
climate were independent predictors of higher precaution use.
Conclusions: Results emphasize the importance of organizational influence on nurses’
HD safe handling precaution use and suggest fostering a positive workplace safety
climate and reducing barriers as interventions.
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CHAPTER I
INTRODUCTION
Over five and one half million healthcare workers (HCWs) are potentially
exposed to hazardous drugs (HDs) in the workplace. While most drugs defined as
hazardous are cytotoxic agents used in the treatment of cancer, many drugs used for other
indications and in other patient populations are equally unsafe. The Occupational Safety
and Health Administration [OSHA] acknowledged this occupational risk and issued
recommendations for the safe handling of HDs more than twenty years ago (OSHA,
1986). According to the National Institute for Occupational Safety and Health [NIOSH]
(2004), there is documented evidence of contamination of the work environment with
HDs, which increases the potential for exposure by nurses, pharmacists and other
healthcare workers when these agents are handled inappropriately.
Occupational exposure to HDs has been associated with acute symptoms such as
hair loss, abdominal pain, nasal sores, contact dermatitis, allergic reactions, skin injury,
and eye injury (Harrison, 2001). Adverse reproductive outcomes have been identified in
many studies of nurses and pharmacists working with HDs, including fetal loss,
miscarriage, or spontaneous abortions (Selevan, Lindbohm, Hornung, & Hemminki,
1985; Stucker et al., 1990; Valanis, Vollmer, & Steele, 1999); fetal abnormalities;
(Hemminki, Kyyronen, & Lindbohm, 1985); infertility (Fransman et al., 2007; Martin,
2005; Valanis, Vollmer, Labuhn, & Glass, 1997); preterm births and learning disabilities
1
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in offspring (Martin, 2005). Furthermore, consistent with the inherent carcinogenic
potential of many HDs, there is an increase in the risk of cancer among occupationally
exposed individuals (Hansen & Olsen, 1994; Martin, 2003; Skov et al., 1992).
The best way to protect workers from a hazardous exposure is by elimination or
substitution of the hazard, but this is not feasible with drug therapy. Next on the hierarchy
of controls (U.S. Department of Labor, 1998) is the use of engineering controls to isolate
or contain the hazard to prevent worker exposure. Education and training of those
responsible for HD handling are examples of administrative controls, the next level of
protection. The last level of protection is personal protective equipment (PPE) which is
barrier protection between the worker and HDs, and is effective only when the worker
uses PPE.
Safe handling precautions include the use of safety equipment, work practices and
PPE. All precautions, when used consistently, can reduce occupational exposure to HDs
(NIOSH, 2004). Given the potentially serious consequences of HD exposure, one would
expect that the use of safe handling precautions is high; however, safe handling
precautions have neither been universally implemented by all nurses nor in all settings.
Several studies on PPE use have been published since 1986, and all reported glove and
gown use that was lower than current recommendations (Mahon et al., 1994; Martin &
Larson, 2003; Nieweg, deBoer, Dubbleman et al., 1994; Stajicj, Barnett, Turner, &
Henderson, 1986; Valanis, McNeil, & Driscoll, 1991; Valanis & Shortridge, 1987;
Valanis, Vollmer, Labuhn, Glass, & Corelle, 1992).
While many researchers have measured how often nurses use HD safe handling
precautions, few studies have measured the impact of specific factors on nurses’ use of
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HD safe handling precautions. Understanding factors that promote or interfere with HD
safe handling precautions may help to develop targeted interventions to increase their
use.
Several factors are thought to influence the adoption of protective behaviors.
These are knowledge about the hazard (Gershon et al., 1995; McGovern, Gershon,
Rhame, & Anderson, 2000), perceived risk of harm (Levin, 1999; Martin, 2006), beliefs
about personal susceptibility to harm (Brewer et al., 2007) perceived benefits of action
(Lusk, Ronis, & Hogan, 1997) interpersonal influences (Hong, Lusk, & Ronis, 2005;
Lusk et al., 1997) and personal and organizational factors (Gershon et al., 1999; Gershon
et al., 1995). While these factors have been explored for other types of occupational
health-protective behaviors, such as use of Universal Precautions (UP) (Gershon et al.,
2000; Gershon et al., 1999; Gershon et al., 1995), hearing protection devices (HPDs)
(Hong et al., 2005; McCullagh, Lusk, & Ronis, 2002; Ronis, Hong, & Lusk, 2006) and
eye protection (Lipscomb, 2000) few studies have explored factors that influence nurses’
use of precautions for HD handling.
Purpose and Significance
Exposure to hazardous chemicals in the workplace is a significant occupational
problem for nurses. Nurses and other HCWs are subject to HD exposure during routine
activities related to patient care. Exposure is associated with a risk of adverse health
outcomes. Use of safety precautions can reduce nurses’ HD occupational exposure
(NIOSH, 2004).
Despite the availability of safety guidelines for more than twenty years (OSHA,
1986), use of protective equipment is less than ideal. Recent studies found that 25-40% of
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nurses used improper gloves for chemotherapy handling and up to 69% of nurses failed to
wear gowns (Martin & Larson, 2003; Polovich & Martin, 2008, February). The reasons
that some nurses do not incorporate safety precautions into their practice are not fully
understood. Knowledge about nurses’ decision to use safety precautions is necessary to
provide guidance in designing interventions to increase their use and reduce hazardous
exposures.
The purpose of this study was to examine factors that are thought to influence the
use of HD safe handling precautions. Identifying factors that predict the use of HD safe
handling precautions is essential to the consistent implementation of these measures. This
study provides valuable information to promote safety for nurses doing hazardous work.
Reducing exposure to HDs will decrease the potential for adverse health outcomes and
improve the safety and quality of life for nurses.
The following aims, hypotheses and research questions were proposed:
Specific Aim 1: Determine the influence of individual and organizational factors
on nurses’ use of safe handling precautions for nurses exposed to HD in their practice.
Hypothesis 1a: Nurses’ individual characteristics (higher knowledge, higher
perceived risk of harm from HD exposure, higher self-efficacy for using PPE and fewer
perceived barriers to using PPE) will be associated with an increased use of HD safe
handling precautions.
Hypothesis 1b: Organizational factors (better workplace safety climate and
interpersonal influences) will be associated with increased use of safe handling
precautions.
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Hypothesis 1c: Nurses’ individual characteristics (higher knowledge, higher
perceived risk of harm from HD exposure, higher self-efficacy for using PPE, fewer
barriers to using PPE) and organizational factors (better workplace safety climate and
interpersonal influences) will each account for significant variance in use of safe handling
precautions.
Research Question 1d: Does nurses’ perceived conflict of interest (need to protect
self vs. need to provide medical care) moderate the relationship between self-efficacy for
using PPE and use of safe handling precautions?
The secondary aim of the study was to determine nurse managers’ perspectives on
use of safe handling precautions in the workplace. The research questions were:
Research Question 2a: What are nurse managers’ perceptions of the
organizational safety climate for safe handling precautions?
Research Question 2b: For nurses they supervise, what are nurse managers’
perceptions of nurses’ use of safe handling precautions?
Theoretical Framework
The use of safe handling precautions, particularly PPE, is conceptualized as selfprotective behavior. DeJoy (1996) describes several theoretical models that are applicable
to workplace self-protective behavior. Some are expectancy-value models, such as the
Health Belief Model (HBM) (Janz & Becker, 1984) and the Theory of Planned Behavior
(TPB) (Ajzen, 1991) which are based on threat-related beliefs or perceptions about a
behavior. They incorporate concepts related to an individual’s attitudes, beliefs, and
expectations about health threats, and are often referred to as cognitive models.
Contextual or environmental models take into account the interaction between the person
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and the situation or environment that influences behavior. Some examples are the
PRECEDE model (Dejoy, 1986) and the Health Promotion Model (HPM) (Pender,
Murdaugh, & Parsons, 2006). Because these models include individual and
environmental factors, they are referred to as integrative models (Peterson & Bredow,
2003). Another category includes behavior models that focus on the process, and describe
behavior change in terms of stages, such as the Transtheoretical Model (Prochaska,
DiClemente, & Norcross, 1992) and the Precaution Adoption Process (Weinstein, 1988).
These models propose that factors relevant to adopting protective behaviors vary
depending on the readiness of individuals to alter their behavior. All of the abovementioned perspectives have been used to explain self-protective behavior; however, the
process models are not well-studied in HCWs and there is less support for their
usefulness in those settings.
The Factors Predicting Use of HD Safe Handling Precautions (PHDP) model was
used for this study (Figure 1). It is a model adapted from the Predictors of Use of Hearing
Protection Model (PUHPM) (Lusk et al., 1997) which was derived from the HPM
(Pender et al., 2006). The HPM is based on three theories: The Theory of Reasoned
Action (Ajzen & Fishbein, 1980) the Theory of Planned Behavior (Ajzen, 1991) and
Social Cognitive Theory (Bandura, 1999).
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Perceived
Risk
Knowledge of the
Hazard

Self Efficacy
Perceived
Barriers

Perceived
Conflict of
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Safe Handling
Precautions
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Influence:
Safety climate &
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Adapted from: Lusk, Ronis
& Hogan, 1997

Figure 1. Factors Predicting Use of HD Safe Handling Precautions
The variables in the PHDP are knowledge about HD exposure, perceived risk of
harm from HD exposure, self-efficacy for using PPE, barriers to using PPE,
organizational safety climate and workplace interpersonal influences, and perceived
conflict of interest between protecting self and providing patient care. The theoretical
predictor variables and their relationships are discussed below.
Safe Handling Precautions. The use of HD safe handling precautions is the
behavior of interest. It is a specific type of self-protective behavior, and includes the use
of safety equipment, work practices and PPE.
Knowledge about HD exposure is defined as information about both the risks of
HD exposure and the effectiveness of precautions in preventing exposure. Knowledge is
necessary for an individual to begin thinking about a health hazard. The PUHPM includes
“benefits of use,” also called “value of use,” which is characterized as an attitude in the
model, but is dependent upon knowledge. For example, an item in the Use of Hearing
Protection Questionnaire (Lusk, 2006) “wearing hearing protection protects me against
hearing loss from noise exposure” reflects knowledge related to HPD use.
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Perceived risk is a cognitive process where individuals consider the seriousness of
a threat, personal susceptibility, personal severity, and short and long-term threat related
to a situation. Individuals are not likely to engage in risk-reducing behaviors until they
recognize personal susceptibility (Brewer et al., 2007). The Health Belief Model (Janz &
Becker, 1984) the Precaution Adoption Process (Weinstein & Sandman, 1992) and an
extended Theory of Planned Behavior (Levin, 1999) all include perceived risk as a
predictor of behavior. The HPM does not include the concept of risk as a motivator, but
was originally designed to explain health-promoting behaviors. Use of PPE is a healthprotective behavior, rather than health-promoting. Motivation for protective behavior
must necessarily consider the concept of risk. It is proposed that knowledge of HD
exposure is related to perceived risk of harm from HD exposure and that perceived risk is
positively related to the use of HD safe handling precautions.
Self-efficacy is the judgment of a person’s ability to carry out a particular
behavior. According to the PUHPM model, self efficacy has a direct effect on HPD use
(Lusk et al., 1997). Self-efficacy is related to knowledge. Additionally, higher self
efficacy decreases the perception of barriers to performing a health-protective behavior
(Pender et al., 2006; Ronis et al., 2006). In the PHDP model, self-efficacy refers
specifically to use of PPE for HD protection.
Barriers are impediments to engaging in a behavior that a person decides to
adopt. These barriers may include “unavailability, inconvenience, expense, difficulty, or
time-consuming nature of a particular action” (Pender et al., 2006, p. 53). Perceived
barriers are expected to be negatively related to self-efficacy as well as the use of safe
handling precautions. In the PHDP model, barriers are those that interfere with PPE use.
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Organizational influence refers to perceptions by an employee about the
commitment of the employer to promote a safe work environment. A positive
relationship was found between organizational commitment to safety and compliance
with UP (Gershon et al., 2000; Gershon et al., 1999; Gershon et al., 1995). Organizational
influence is proposed to affect HD safe handling precautions in several ways: a direct
effect on use of precautions; an indirect effect by decreasing perceived barriers; and an
indirect effect by increasing social modeling of precaution use.
Interpersonal influence in the workplace is part of the organizational climate, and
refers to the impact of important others’ attitude toward and encouragement of the use of
protective equipment. This includes social modeling, which is a significant predictor of
HPD use (Hong et al., 2005; Lusk et al., 1997). The findings in HPD studies indicate that
workers are more likely to use protective equipment if their co-workers do. This had not
been previously studied with HD safe handling precautions and the same relationship was
anticipated, although not supported by this study.
Perceived conflict of interest is defined by Gershon and others as a conflict
“between workers’ need to protect themselves and their need to provide medical care to
patients” (1995, p. 225). It is a specific type of “immediate competing demand” in the
revised HPM (2006) but the variable is not well studied. In one report, HCWs with low
levels of conflict of interest were more than twice as likely to comply with UP as those
with high levels (Gershon et al., 1995). Higher perceived conflict of interest is expected
to interfere with HD precaution use.
The proposed model of factors influencing the use of HD safe handling
precautions is adapted from a model that has consistently predicted HPD use, a type of

10
protective behavior. Perceived risk is included because it is an important variable in other
health behavior models and the fact that it predicts other health-protective behaviors.
Perceived conflict of interest is included because it affects UP use, which is similar to HD
precaution use. Because of the suggested relationships between organizational influences
and the other predictor variables, this variable is proposed to strongly predict the use of
HD safe handling precautions.
The HPM emphasizes the role of behavior-specific factors on the outcome of
interest (Pender et al., 2006). It is essential to identify factors that are salient to each
particular type of self-protective behavior. PPE use by HCWs is a specific self-protective
behavior that is undertaken by an individual for the purpose of protection against a future
adverse health effect, and it requires ongoing adherence over a long period of time. The
PHDP model represents an adaptation of the HPM and the PUHPM to include those
factors with high relevance to this self-protective behavior.
The uniqueness of the healthcare environment suggests the need for specific
predictors. Nurses work most often as employees rather than as independent practitioners
in hospitals, clinics, or physician office practices; therefore, organizational influence is
expected to affect PPE use. The PHDP proposes that organizational commitment to
safety has a direct effect on use of precautions. This relationship is supported in several
studies of UP use (Gershon et al., 2000; Gershon et al., 1995; Stone, Du, & Gershon,
2007; Stone & Gershon, 2006).
Perceived conflict of interest is another factor that is unique to patient care
situations. This concept is not a part of the PUHPM because it is not relevant to HPD use.
The PHDP incorporates perceived conflict of interest because it is particularly relevant to
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HCWs’ use of self-protective behavior (Gershon et al., 1995; Lymer, Richt, & Isaksson,
2004).
To summarize the proposed relationships of the PHDP model, depicted in Figure
1, knowledge of the hazard is related to perceived risk and self-efficacy. Self efficacy is
expected to decrease perceived barriers. Organizational influences are expected to
decrease perceived barriers. Perceived risk, self-efficacy, perceived barriers,
organizational influences and interpersonal influences are expected to influence use of
safe handling precautions. Finally, perceived conflict of interest is proposed to influence
the use of safe handling precautions.
Assumptions
The following are assumptions inherent in the PHDP:
•

Individuals value health and therefore seek to protect their health

•

Individuals strive to regulate their own behavior

•

Individuals are complex beings who interact with their environment

•

Organizations differ in their values related to health and safety

•

Clinical situations are unique situations that influence HCWs’ priorities

The most important assumption related to the PHDP is that self-protective
behavior is not a function of individual motivation alone. The workplace environment
influences how and when workers engage in self-protective behavior. Healthcare
organizations promote patient health and safety, but worker safety may vary in priority
from one setting to another. In addition, HCWs may feel as though they must choose
between their own safety and the safety of patients in care situations (Gershon et al.,
1995; Lymer et al., 2004). The findings from one qualitative study on UP precautions
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prompted the authors to comment, “On a conceptual level, this means that noncompliance [with precautions] must be conceived as being a natural tendency in clinical
work” (Lymer et al., 2004, p. 548).

CHAPTER II
LITERATURE REVIEW
This chapter provides an overview of the adverse effects of occupational exposure
to hazardous drugs; a summary of recommended HD safe handling precautions; and
factors that are thought to influence the use of protective behaviors.
Adverse Effects of Occupational Exposure to Hazardous Drugs
Evidence of the adverse effects of HD exposure has been available since the
1970’s. Several chemotherapy agents were linked to secondary leukemia and other
cancers in patients who received antineoplastic agents for primary, un-related
malignancies (Harris, 1976; Penn, 1976; Rosner, 1976). This information was soon
followed by concern that the risk might extend to healthcare workers exposed to the
drugs in the course of their work (Donner, 1978; Ng & Jaffe, 1970). Lancet published the
first convincing evidence of health care worker exposure in a letter to the editor in 1979
(Falck et al.). In a small but controlled study, mutagenic activity was found in the urine of
patients who received chemotherapy and nurses who administered the chemotherapy. The
investigators had intended the nurses to be the control group, but instead found evidence
of their exposure. In several recently published studies, hazardous drugs have been
measured in the urine of nurses, pharmacists and pharmacy technicians (Pethran et
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al., 2003; Sessink & Bos, 1999; Wick, Slawson, Jorgenson, & Tyler, 2003), indicating
that there has been little reduction in exposure in over twenty-five years.
Acute symptoms have been reported in nurses and pharmacists who were
occupationally exposed to HDs. These include hair loss, abdominal pain, nasal sores,
contact dermatitis, allergic reactions, skin injury, and eye injury (Harrison, 2001; Valanis,
Vollmer, Labuhn, & Glass, 1993a, 1993b). Adverse reproductive outcomes have been
identified in nurses and pharmacists working with HDs, including miscarriage (OR =
1.01, p = .03) (Martin, 2003), spontaneous abortions (OR = 1.5-2.3) (Selevan et al., 1985;
Stucker et al., 1990; Valanis et al., 1999); fetal abnormalities (OR = 4.7, p = .02)
(Hemminki, et al., 1985); infertility (OR = 1.42-1.5) (Martin, 2003; Valanis et al., 1997)
longer time to conception (OR = .8) (Fransman et al., 2007); preterm labor (OR = 2.98,
p< .01), preterm births (OR = 5.56, p < .01) and learning disabilities (OR = 2.56, p < .01)
in offspring of nurses exposed during pregnancy (Martin, 2005). Consistent with the
inherent carcinogenic potential of twenty-three chemotherapy agents (International
Agency for Research on Cancer, 2007), there is an increased relative risk (RR) of cancer
among occupationally exposed pharmacy technicians (RR = 1.1-3.6) (Hansen & Olsen,
1994) and nurses (RR = 10.65) (Skov et al., 1992). More recently, Martin (2003) found
that exposed nurses were significantly more likely to report a cancer diagnosis than
unexposed nurses (OR = 3.27, p = .03). In that study, the nurses’ age at initial cancer
diagnosis was younger than that reported in the Surveillance, Epidemiology, and End
Results [SEER] Data (National Cancer Institute, 1999).
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Safe Handling Precautions for HD Handling
Since exposure to HDs is associated with adverse outcomes, safe handling
precautions are recommended to reduce or eliminate exposure for health care workers.
The first guidelines were published by the American Society of Hospital Pharmacists
(ASHP, 1985), and these influenced the Occupational Safety and Health Administration
document (OSHA, 1986). Professional organizations such as the American Medical
Association [AMA] (1985) and the Oncology Nursing Society [ONS] (Polovich,
Whitford, & Olsen, 2009) and NIOSH, a governmental agency (2004) have published
similar guidelines. The recommended methods for reducing HD exposure include 1)
biological safety cabinets (BSCs) to protect against inhalation exposure during drug
preparation; 2) two pairs of disposable gloves that are powder free and have been tested
for use with HDs; 3) a disposable gown made of chemical-protective fabric with long
sleeves, cuffs and back closure; 4) A NIOSH-approved respirator to protect against
aerosols; 5) eye and face shield that provides splash protection; 6) administrative controls
and 7) careful work practices to reduce opportunities for exposure. All precautions, when
used consistently, can reduce occupational exposure to HDs (NIOSH, 2004; OSHA,
1995).
Given the risks of exposure, use of safe handling precautions should be high;
however, safe handling recommendations have not been universally implemented.
Several studies on PPE use for HD handling have been published since the 1986 OSHA
guidelines (Mahon et al., 1994; Martin & Larson, 2003; Nieweg et al., 1994; Stajicj et al.,
1986; Valanis et al., 1991; Valanis & Shortridge, 1987; Valanis et al., 1992). These
studies reported variation in PPE use by nurses based on the type of HD handling
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activity. Glove use ranged from 49-99% for drug preparation and 15-94% for drug
administration; while gown use ranged from 3-63% for drug preparation and 3-31% for
drug administration. Not all studies reported PPE use for handling patient’s HDcontaminated excretions and for disposal of chemotherapy, but when reported it ranged
from 58-96% for gloves and 4-23% for gowns (Martin & Larson, 2003; Polovich &
Martin, 2008, February; Valanis et al., 1991).
The PPE studies published before 1990 demonstrated the lowest glove use (Stajicj
et al., 1986; Valanis & Shortridge, 1987). All of the PPE studies published after 1990
demonstrated higher glove use for HD preparation and administration (Mahon et al.,
1994; Martin & Larson, 2003; Nieweg et al., 1994; Valanis et al., 1991; Valanis et al.,
1992), but it still fell short of recommendations. Recent studies continue to report less
frequent PPE use for handling HD-contaminated excretions and drug disposal. In
addition, the newer guidelines (ASHP, 2006; NIOSH, 2004; Polovich et al., 2009)
recommend double gloves for all HD handling activities. In one recent study, adoption of
this precaution was only 11-18% (Polovich & Martin, 2008, February).
Many studies did not report the type of gloves used for HD handling. Two studies,
however (Martin & Larson, 2003; Polovich & Martin, 2008, February) found that 2540% of nurses used gloves not designated for use with chemotherapy. They found that
nurses working in private physician office practices where chemotherapy is prepared and
administered were less likely to have access to appropriate PPE. Because permeation
studies indicate that many medical gloves provide limited protection from HDs (Connor,
1999; Gross & Groce, 1998; Klein, Lambov, Samev, & Carstens, 2003; Singleton &
Connor, 1999), not all gloves are appropriate for HD handling. This is particularly
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important because hands are the most frequent site of dermal exposure to HDs
(Fransman, Vermeulen, & Kromhout, 2004, 2005).
Gowns are recommended for HD handling in all published guidelines. Most
studies indicate that gowns are used more frequently for HD preparation than for HD
administration, although overall gown use does not meet OSHA guidelines (Mahon et al.,
1994; Martin & Larson, 2003; Nieweg et al., 1994; Valanis et al., 1991; Valanis &
Shortridge, 1987; Valanis et al., 1992). Additionally, some studies have reported that
nurses wear gowns made of cloth and other materials that are not designated for HD
handling (Mahon et al., 1994; Martin & Larson, 2003; Polovich & Martin, 2007, March;
Valanis & Shortridge, 1987). Such gowns provide limited protection against chemical
permeation (Connor, 1993; Harrison & Kloos, 1999) and should not be used for HD
handling. In addition, Polovich & Martin (2008, February) found 58% of nurses reported
reusing disposable gowns for HD preparation and 38% of nurses reused disposable
gowns for HD administration. Reuse of disposable gowns may increase the chance of
contaminating clothing.
To date, there have been eight published studies on PPE use with chemotherapy
(Mahon et al., 1994; Martin & Larson, 2003; Nieweg et al., 1994; Polovich & Martin,
2008, February; Stajicj et al., 1986; Valanis et al., 1991; Valanis & Shortridge, 1987;
Valanis et al., 1992) (See Table 1). All of the studies that measured use of HD safe
handling precautions were descriptive, cross-sectional studies. One study used a
comparative design in reporting nurses’ and pharmacists’ use of safe handling
precautions before and after publication of OSHA guidelines (Valanis et al., 1992). Two
studies examined relationships between the use of HD safe handling precautions and
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nurse characteristics (such as years of experience) and work site characteristics (such as
type of setting) (Martin & Larson, 2003; Polovich & Martin, 2008, February).
Table 1
Studies of Safe Handling Precautions
Authors
Stajicj et al., 1986

Sample

Reported PPE Use

33 registered nurses

Drug preparation:

employed in oncologists’

Gloves = 49% Gowns = 3%

private practices in

Drug administration:

Georgia

Gloves = 15% Gowns = 3%

Valanis &

632 ONS members who

Drug preparation:

Shortridge, 1987

mix and/or administer

Gloves = 76% Gowns = 36%

antineoplastic drugs.

Drug Administration:
Gloves = 50% Gowns = 14%

Valanis et al., 1991

125 staff from 14 facilities

Drug preparation:

in Southwestern Ohio,

Gloves =91% Gowns = 41 %

including 7 physicians, 93

Drug administration:

nurses, 22 pharmacists &

Gloves = 78% Gowns = 12%

technicians, and 3 nurse
aides/ housekeeping staff
Valanis, et al., 1992

1932 nurses and 153

Drug preparation:

nurses aides from >200

Gloves = 92% Gowns = 63%

health care facilities

Drug administration:

currently handling HD’s

Gloves = 82% Gowns = 23%
Handling excreta
Gloves = 67% Gowns = 4%

(Table 1 Continues)
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(Table 1 Continued)
Authors
Mahon et al., 1994

Sample
103 nurses, 83 of whom

Reported PPE Use
Drug preparation:

handle chemotherapy, from Gloves = 90% Gowns = 44%
an ONS chapter in a large

Drug administration:

Midwestern city.

Gloves = 94% Gowns = 59%
Patient care:
Gloves = 94% Gowns = 12%

Nieweg et al., 1994

824 nurses from 11 Dutch

Drug administration:

hospitals

Gloves = 91% Gowns = 21%
Mask = 18%

Goggles = 3%

Martin & Larson,

263 ONS members; nurses

Drug preparation:

2003

from outpatient settings

Gloves = 99% Gowns = 53%
Drug administration:
Gloves = 94% Gowns = 31%
Handling excretions:
Gloves = 96% Gowns = 23%

Polovich & Martin,

330 nurses attending an

Drug preparation:

2008

ONS conference from

Gloves = 98% Gowns = 91%

various settings who

Drug administration:

handle chemotherapy

Gloves = 99% Gowns = 84%
Drug disposal:
Gloves = 99% Gowns = 75%
Handling excreta:
Gloves = 99% Gowns = 77%

Each study evaluated PPE use by self-report measures. Instrument content
validity was evaluated using experts in all studies except one (Nieweg et al., 1994) in
which validity was not reported. Martin & Larson (2003) reported observing PPE use in
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ten study participants, which matched their self-report for all but two items. Reliability
was most often evaluated using test-retest procedures with kappa reported in the range of
.64-1.0 (Martin & Larson, 2003; Valanis & Shortridge, 1987; Valanis et al., 1992).
Three studies included participants who were members of ONS (Mahon et al.,
1994; Martin & Larson, 2003; Valanis & Shortridge, 1987) and one recruited participants
from a national ONS conference (Polovich & Martin, 2008, February). It is estimated that
only 50 % of practicing oncology nurses in the United States are ONS members (A.
Stengel [ONS Membership Services], personal communication, December 3, 2007).
Because of the educational resources of the organization, ONS members may be biased
toward better handling practices. No studies have examined use of PPE by nurses who
administer HDs for non-oncology indications such as rheumatoid arthritis, multiple
sclerosis, or tubal ectopic pregnancy. Thus, samples in these studies are not likely
representative of all nurses handling HDs. The current study sought to include nurses
who are not members of ONS as well as members in order to obtain a sample that is more
representative of nurses handling chemotherapy in the U.S.
In summary, the use of PPE has improved over time. In the 20 years since the
OSHA Guidelines, oncology nurses have incorporated the use of gloves for handling
HDs into their practice. Some areas of concern remain, such as the fact that
chemotherapy-designated gloves are not used in all settings; that double-gloves are used
infrequently; that some nurses do not wear gloves for all HD handling activities; and that
gown use continues to be low. Appropriate PPE may not always be available.
Additionally, nothing is known about nurses’ adherence to HD safe handling precautions
outside of oncology settings.
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Requirements for Hazardous Drug Handling
OSHA standards are part of the Code of Federal Regulations (CFR) and have the
force of law. One example is the OSHA Bloodborne Pathogen Standard (U.S.
Department of Labor-OSHA, 1991) which requires blood and body fluid precautions and
use of safe needle devices in healthcare (OSHA, 2007). OSHA has the authority to cite
and fine organizations that fail to provide appropriate safety equipment and precautions
to its employees. In contrast, HD safe handling recommendations are guidelines rather
than mandates from OSHA. This fact has led some organizations to consider the OSHA
HD guidelines optional.
Selected aspects of the OSHA HD guidelines are required by other standards.
These applicable standards include the Hazard Communication Standard (29CFR
1910.1200), which requires employers to inform employees of the risks of hazardous
materials in their workplace and the methods of protecting themselves. The same
standard requires Material Safety Data Sheets (MSDS) to be available for all chemical
hazards (OSHA, 1994). Recent regulations regarding HD preparation (U.S.
Pharmacopeial Convention, 2008) have elevated the OSHA recommendations to
standards that are enforceable by the Food and Drug Administration (FDA).
Employers’ responsibilities are outlined in the OSHA guidelines and the NIOSH
recommendations. According to the recommendations, employers should have policies &
procedures for safe handling; provide hazard communication training; provide a BSC for
drug preparation; provide appropriate PPE for those handling HDs; have MSDS’s
available for all HDs, and monitor potentially-exposed employees in a medical
surveillance program.
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In summary, regulations regarding employee safety when handling HDs are not
consistent with the recommendations. While some components of workplace HD safety
programs are regulated, others are not. Consequently, organizations vary in their
interpretation of HD safety requirements, resulting in variable implementation of HD safe
handling precautions.
Factors Influencing Adoption of Protective Behaviors
The use of safe handling precautions can be described as protective behavior.
Little is known about the factors contributing to nurses’ decision to use safe handling
precautions when handling HDs; however, use of protective equipment for protection
against other occupational hazards such as blood and body fluids (Gershon et al., 1995)
high noise (McCullagh et al., 2002), industrial chemicals (Geer, Curbow, Anna, Lees, &
Buckley, 2006) and eye injury (Forst et al., 2006) has been examined. Worker protective
behavior for other occupational hazards is thought to be influenced by personal factors
(Gershon et al., 1999; Gershon, Sherman, et al., 2007; Hong et al., 2005; McGovern et
al., 2000), knowledge about the hazard, (Geer et al., 2006; Gershon et al., 1995;
Raymond, Hong, Lusk, & Ronis, 2006), perceived risk of harm, (Gershon et al., 1995;
Levin, 1999; Martin, 2006), self-efficacy (Kerr, Lusk, & Ronis, 2002; Lusk, Kerr, Ronis,
& Eakin, 1999; Lusk, Ronis, & Baer, 1995; Lusk et al., 1997; Lusk, Ronis, Kerr, &
Atwood, 1994; Raymond et al., 2006; Ronis et al., 2006) barriers (Forst et al., 2006;
Gershon et al., 1995; Kerr et al., 2002; Lusk et al., 1994; McCullagh et al., 2002)
organizational influences (Gershon et al., 2000; Gershon et al., 1995; Stone et al., 2007;
Stone & Gershon, 2006) interpersonal influences, [modeling and encouraging PPE use by
co-workers] (Lusk et al., 1997; McCullagh et al., 2002; Raymond et al., 2006; Ronis et
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al., 2006) and situational factors (Gershon et al., 1995; Hong et al., 2005; McCullagh et
al., 2002).
Personal Factors
Individual characteristics may affect the adoption of protective behaviors. The
effect of years of experience on precaution use reported in the literature is inconsistent.
More years of experience was associated with higher UP use in healthcare workers
(McGovern et al., 2000) and HPD use among White automotive manufacturing workers
(Hong et al., 2005). In contrast, years of working in a plant negatively predicted HPD use
among automotive manufacturing workers (Raymond et al., 2006) and construction
workers (Lusk et al., 1997; Ronis et al., 2006). In two large descriptive studies of nurses
handling HDs (Martin, 2006; Martin & Larson, 2003), nurses with fewer years of
oncology experience were more likely to wear gowns when handling HDs and nurses
with more years of experience generally had a lower perceived risk of harm from HD
exposure. Since personal factors are not modifiable, this is not a primary variable of
interest in this study. However, these data were collected for descriptive purposes and for
their potential use as covariates.
Knowledge of the Hazard
People must be aware of the existence of a hazard in order to know that they
should protect themselves from the hazard (Weinstein 1988; Weinstein, Lyon, Sandman,
& Cuite, 1998; Weinstein & Sandman, 1992). In studies of dermal chemical exposure in
industrial settings, workers’ lack of knowledge about characteristics of chemicals that
affect skin absorption was associated with lower use of protective equipment (Geer et al.,
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2007; 2006). In healthcare settings, more knowledge about human immunodeficiency
virus (HIV) transmission (Gershon et al., 1995; McGovern et al., 2000) and training in
PPE use (Gershon et al., 1995; McGovern et al., 2000) have been associated with
statistically significant better UP compliance.
Regarding HD safe handling precautions, Ben Ami and colleagues found that
lower use of precautions was related to lack of knowledge (Ben Ami, Shaham, Rabin,
Melzer, & Ribak, 2001) and Harrison and colleagues found that education and training
improved HD safe handling (Harrison, Godefroid, & Kavanaugh, 1996).
In a study of nurses working in outpatient and office-based oncology settings,
Martin and Larsen (2003) found that oncology certified nurses were less likely than those
nurses who were not oncology certified to use gowns while disposing of chemotherapy
and handling excreta contaminated with HDs. Since certification examinations measure
knowledge, nurses with a higher level of knowledge would be expected to be more aware
of the risks of HD exposure, and thus more likely to use PPE. No workplace
characteristics were suggested to account for this unexpected finding, which warrants
further exploration.
Perceived Risk of Harm from HD Exposure
Risk perceptions are important in situations where individuals make decisions to
engage in a protective behavior (Brewer et al., 2007). Brewer asserts that there are three
dimensions of perceived risk: perceived likelihood, perceived susceptibility and
perceived severity, and that each is related to the threat of harm when no action is taken.
In a meta-analysis, Brewer and colleagues examined thirty-four studies (N = 15,988) to
test the hypotheses that higher perceived likelihood, perceived susceptibility and severity
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are associated with adults obtaining vaccinations. All three dimensions of risk perception
significantly predicted vaccination behavior, showing a consistent relationship between
risk perception and the adoption of a specific protective behavior (Brewer et al., 2007).
Only three descriptive studies have reported perceived risk related to PPE use for
HD handling. In the first, a study of 632 nurses who mix and/or administer antineoplastic
drugs, 25% reported they did not believe there is danger as one reason for not using PPE
(Valanis & Shortridge, 1987). Valanis and others (1991) reported a lack of awareness of
risk associated with HD handling among 9% of nurses and physicians. In the third study,
Martin (2006) examined the relationship between the degree of perceived health risk
associated with handling chemotherapy and the use of precautions by 500 randomlyselected nurses working in outpatient oncology settings. Fifty percent of nurses indicated
that the drugs were “minimally hazardous” and 5% described the drugs as “not
hazardous.” Since these nurses worked in outpatient and office-based oncology practices
primarily administering chemotherapy, there is no reason to suspect that these nurses
handled drugs that were less hazardous than their colleagues. The degree of perceived
risk of harm from HD exposure was lower among nurses with more years of oncology
and chemotherapy experience. More importantly, the use of gowns was significantly
lower among those nurses with lower perceived risk. Similar results were found in studies
of compliance with UP in general (Gershon et al., 1995) and the use of gloves when
potentially exposed to blood (Levin, 1999).
Self Efficacy for use of Personal Protective Equipment
Perceived self efficacy is “the judgment of personal capability to organize and
carry out a particular course of action” (Pender et al., 2006, p. 53), and is an important
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concept in several health behavior models. In the context of occupational health, this
variable was found to predict HPD use (Kerr et al., 2002; Lusk et al., 1999; Lusk et al.,
1995; Lusk et al., 1997; Lusk et al., 1994; Raymond et al., 2006; Ronis et al., 2006). Self
efficacy is not well studied in relation to blood and body fluid exposure. The effect of
self-efficacy on UP compliance has been mixed, with one study finding a relationship
(Sinclair, 1998) and two studies finding none (Mitchell, 1995; Patros, 2002), although the
latter studies may have been under-powered because of small sample size. Self efficacy
for PPE use was not significantly related to protective behavior for chemical exposure in
industrial settings (Geer et al., 2007). This variable has not been studied in HD handling,
but was included because of its relationship to some other health protective behaviors and
conceptual links in the model.
Barriers to Using Personal Protective Equipment
Barriers interfere with workers’ use of protective behaviors. They may be
practical (such as lack of available protective equipment), psychosocial (e.g. peer or
patients’ attitudes) or situational (such as time constraints). Perceived barriers are
negatively related to HPD use (Kerr et al., 2002; Lusk et al., 1994; McCullagh et al.,
2002), UP compliance (Gershon et al., 1995) and workers’ use of eye protection (Forst et
al., 2006). The most commonly reported barriers to using PPE across occupational
settings are time pressure or lack of time, peer acceptability, and negative outcome
expectancy (Geer et al., 2006).
A few studies have reported barriers to using HD safe handling precautions. Three
studies reported reasons for not wearing PPE identified by nurses or pharmacists (Mahon
et al., 1994; Valanis et al., 1991; Valanis & Shortridge, 1987). The findings were similar,
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and included all of the following: lack of time, lack of availability of or accessibility to
PPE, lack of awareness that non-use is potentially hazardous, not being convinced of the
need for PPE, cost of protective equipment, discomfort associated with wearing PPE, and
concern that PPE would upset patients. In a study of chemotherapy gown effectiveness,
Harrison and Kloos (1999) asked participants to rate the subjective comfort of several
gowns. Those gowns that provided the best protection were rated the least comfortable to
wear. The heat-retaining quality of chemical protective gowns is a potential barrier to
use. None of these studies measured the effect of barriers on use of precautions or the
relative importance of certain barriers. Since all barriers cannot be eliminated, it is
essential to gain a better understanding of those factors having the most impact.
Organizational Culture and Safety Climate
The aspects of organizations affecting protective behaviors have been variously
referred to as “organizational culture,” “organizational climate” and “safety climate.”
These terms are defined in the following section.
Organizational culture refers to the underlying principles, norms, values, beliefs,
and assumptions within an organization (Ostroff, 2001). Culture is a highly abstract
construct that encompasses all aspects of work and the work setting. There are many
cultures within healthcare organizations, such as ethical conduct and patient safety
(DeJoy, Schaffer, Wilson, Vandenberg, & Butts, 2004; Gershon, Stone et al., 2007).
Employee safety is the specific culture of interest for this study.
Organizational climate is how culture is experienced by workers, and refers to
employees’ collective perceptions of organizational attributes, such as decision making,
leadership, and norms (Ostroff, 2001). Safety climate is a specific aspect of
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organizational climate, and is defined as employees’ collective perceptions about an
organization’s commitment to providing a safe work environment (Committee on the
Work Environment of Nurses and Patient Safety Board on Health Care Services, 2004;
Cooper & Phillips, 2004). The terms culture and climate are sometimes used
interchangeably, and they are related. Their relationship is described as follows: “Climate
follows naturally from culture or, put another way, organizational culture expresses itself
through organizational climate” (Guldenmund, 2000, p. 221). The distinction is
important. Culture is an abstract, more “holistic” construct that encompasses the social
and cultural context of the work situation and is difficult to define (Lymer et al., 2004).
Climate is a concept that is less abstract and has specific components or dimensions that
can be described and defined. There are empirical indicators of safety climate that can
measure those dimensions. Safety culture may be inferred from safety climate, but cannot
be directly measured.
Safety climate can be described along a continuum, as positive, neutral or
negative, depending on workers’ perceived level of the organization’s commitment to a
safe work environment. Employees of the same organization tend to agree about their
perceptions of safety climate (D Zohar, 1980) as evidenced by greater variance of safety
climate scores between workplaces as opposed to within workplaces. Safety climate has
been studied in industrial settings and found to affect safety performance since the
1970’s, and recent work indicates that the same relationship of safety climate to safety
behavior exists in healthcare occupational settings (Dejoy, Gershon, & Schaffer, 2004;
Stone, Pastor, & Harrison, 2006).
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There is, however, some disagreement about the components that contribute to a
better, more positive safety climate. The literature suggests anywhere from three to
twenty-four dimensions of safety climate (Guldenmund, 2000). For example, Zohar
(1980) suggested several organizational dimensions based on industrial safety literature,
and used principle component factor analysis to determine eight important factors. They
are employees’ perceptions of:
•

Importance of safety training programs

•

Management attitudes toward safety

•

Effects of safe conduct on promotion

•

Level of risk at work place

•

Effects of required work pace on safety

•

Status of safety officer

•

Effects of safe conduct on social status

•

Status of safety committee.

Cooper and Phillips (2004) adapted Zohar’s questionnaire and determined that
there are seven dimensions, adding management actions toward safety, while combining
social status with promotion and status of the safety officer with the safety committee.
One author (Guldenmund, 2000) suggests that variation in the dimensions making up
safety climate is likely explained by the difference in industries, populations studied, and
theoretical model used to frame the research.
In healthcare organizations, five components have been suggested as indicators of
a positive safety climate (DeJoy, Murphy, & Gershon, 1995; DeJoy, Searcy, Murphy, &
Gershon, 2000; Gershon, Stone et al., 2007; Moore et al., 2005):
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•

safety policies and procedures exist and compliance with safety policies is
expected

•

education and training in safe practice are provided

•

equipment and supplies necessary for safety are made available

•

the organization provides feedback and reinforcement for safety

•

management provides support for safety programs

It is expected that these aspects of an organization’s safety climate influence
individual healthcare worker’s adoption of protective behaviors. The effects of these
dimensions are described in the following section.
Safety Policies and Procedures
The existence of policies related to employee safety is one indicator of a positive
safety climate (DeJoy, Schaffer et al., 2004). Policies and procedures are overt actions on
the part of management to affect workplace safety. In several early studies related to the
use of HD safe handling precautions, the majority of organizations (> 90%) reported
having written policies regarding HD handling (Mahon et al., 1994; Nieweg, deBoer,
Dubbleman, & et al., 1994; Valanis, McNeil, & Driscoll, 1991). Most participants in
these studies worked in inpatient hospital oncology departments, which were the most
common setting for cancer treatment at the time. In the 1990’s, economic factors shifted
cancer treatment to outpatient settings. In a recent study of outpatient and office-based
oncology settings, Martin and Larson (2003) reported that 85% of outpatient oncology
treatment settings had written policies for HD handling. Polovich and Martin (2008,
February) found that only 71% of physician-based oncology practices had written HD
handling policies, as compared to 90% in all other types of oncology settings. Thus, the
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shift of treatment from hospitals to other types of organizations has impacted the
availability of policies related to HD safe handling.
Policies and procedures requiring the use of personal protective equipment (PPE)
have been shown to enhance the use of such equipment. For example, overall adherence
with universal precautions (UP) for protection against blood and body fluid exposure
increased from 44% to 73% over one year in an emergency department when a policy
mandating UP compliance was instituted (Kelen et al., 1991). In a study outside of
healthcare, Mexican factory workers’ use of hearing protection devices (HPDs) in highnoise environments was 72% - 100% in organizations requiring their use, and 0-27% in
organizations that did not (Kerr, Lusk, & Ronis, 2002). Nurses who reported double
gloving for HD handling were significantly more likely to practice in organizations where
policies required double gloves (Polovich & Martin, 2008, February). The lack of a
policy mandating the use of protective equipment was given as a reason for not using
PPE by nurses for HD safe handling (Nieweg et al., 1994; Valanis et al., 1991; Valanis &
Shortridge, 1987) and by farmers’ for not wearing eye protection (Forst et al., 2006).
The presence of policies alone, though important, may not lead to appropriate use
of PPE; the congruence of policies with existing guidelines was also an important
concern. In two U.S. studies (Valanis et al., 1991; Valanis, Vollmer, Labuhn, Glass, &
Corelle, 1992), the investigators found that policies requiring PPE for various HD
handling activities were less stringent than the OSHA (1986) guidelines. In a European
study, policies were compared to the Netherlands Association of Hospital Pharmacists
(NAHP) guidelines and fell short of those recommendations (Nieweg et al., 1994). More
recently, Polovich and Martin (2008, February) found that 52% of respondents’
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organizations had not updated their HD safe handling policies to reflect the
recommendations made by the NIOSH (2004) two years after their publication.
Individual employees may vary in their compliance with policies. This may be
due to lack of familiarity with the content of policies. In a study by Nieweg and others
(1994), 11% of the nurses indicated that there were no guidelines for HD handling in
their work areas, when in fact all the hospitals involved in the study did have policies. In
another study (Valanis et al., 1991), nurses incorrectly identified the required PPE for
certain HD handling tasks. Interestingly, when nurses assumed that specific PPE was
required by policy, they were more likely to use the PPE, whether or not that was the
case. The authors in both studies concluded that staff members’ knowledge of their
facility’s policies was poor. Other reasons for non-compliance are not well understood.
In summary, policies and procedures are an important aspect of safety climate in
healthcare organizations. The presence of policies influences workers’ use of protective
behaviors. However, organizations vary in their activities related to ensuring that policies
are congruent with current safety recommendations; communicating the content of safety
policies and procedures; and encouraging compliance with policies.
Education and Training
Providing safety training is an important aspect of safety climate. Safety
education and training affect the adoption of safety-related behaviors. Education refers to
providing information, while training is defined as forming by “instruction, discipline or
drill” (Mish, 2004). Safety education provides information to increase knowledge about
workplace hazards. The effect of knowledge on use of precautions was discussed
previously. Safety training concerns actions or behaviors that an employee learns to
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prevent hazardous exposures. In addition to enhancing the knowledge and skills
necessary for implementing safety precautions, the fact that employers provide education
and training regarding safety emphasizes its importance to employees.
Training related to chemical hazards in the workplace is required by the Hazard
Communication standard (OSHA, 1994) as follows: “at the time of their initial
assignment and whenever a new physical or health hazard the employees have not
previously been trained about is introduced into their work area” (p. 470). This training
must include the health risks associated with the hazards as well as what precautions will
protect the employee from exposure. Most often, training occurs during orientation of
new employees. Hospitals generally provide annual updates to comply with requirements
of other regulatory agencies (e.g., The Joint Commission). Other organizations may vary
in the type, specificity (e.g., chemicals or drugs), frequency and duration of training.
Safety knowledge, education and training affect the adoption of safety-related
behavior. The impact of safety training has been measured in several different
occupational settings. Training has been associated with safety behavior as measured by a
safety checklist among manufacturing workers (Cooper & Phillips, 2004); with increased
use of HPDs by automotive factory workers (Lusk et al., 2003); compliance with UP by
nurses (DeJoy et al., 1995; Gershon et al., 1995; McGovern, Gershon, Rhame, &
Anderson, 2000); the use of safe needle precautions among hospital workers (Vaughn et
al., 2004); and the use of infection control practices by dentists (Gershon, Karkashian,
Vlahov, Grimes, & Spannhake, 1998).
The effect of training on the use of HD safe handling precautions is not wellstudied. One study in Israel reported that lack of compliance with safety measures was
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related to lack of education (Ben Ami, Shaham, Rabin, Melzer, & Ribak, 2001). Two
studies on HD handling (Martin & Larson, 2003; Stajich, Barnett, Turner, & Henderson,
1986) reported that nurses had received education about HD handling; however, the
relationship between training and use of precautions was not evaluated. Little is known
about what constitutes the most important content of training and what the most effective
training methods are for increasing the use of HD safe handling precautions.
Equipment and Supplies
In order for workers to use appropriate precautions, safety equipment must be
both available and readily accessible (DeJoy et al., 2000; Moore et al., 2005). In two
large studies of nurses potentially exposed to blood and body fluids, the availability of
PPE was a predictor of the nurses’ compliance with PPE (DeJoy et al., 1995; DeJoy et al.,
2000). In one of those studies, PPE availability not only predicted its use, but in
combination with performance feedback, it accounted for 30% of the variance in a
measure of safety climate (DeJoy et al., 1995). Moore also suggests that by making
adequate supplies of PPE readily available, employees may have increased perceptions of
the effectiveness of PPE in preventing exposure (Moore et al., 2005).
Nurses have reported that appropriate PPE for HD handling is not always
available (Martin & Larson, 2003; Polovich & Martin, 2007, March; Valanis &
Shortridge, 1987). NIOSH recommends that only chemotherapy-tested gloves should be
used for handling HDs. Despite the availability of chemotherapy-designated gloves for
over 15 years, Mahon et al. (1994) reported that only 44% of the nurses used the special
gloves for HD preparation. A more recent study in outpatient chemotherapy settings
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(Martin & Larson, 2003) revealed that 84% of nurses mixing HD’s and 60% of nurses
administering HD’s wore chemotherapy-designated gloves.
For HD handling, cloth gowns or lab coats are not considered PPE because they
do not provide protection from chemical penetration. Several studies found that cloth
gowns were used during HD handling because they were the only protective garments
available (Mahon et al., 1994; Martin & Larson, 2003; Nieweg et al., 1994; Valanis &
Shortridge, 1987; Valanis et al., 1992). PPE availability varied with the type of clinical
setting. Nurses working in private physician office practices where chemotherapy is
prepared and administered were less likely than nurses working in hospital inpatient or
outpatient settings to have access to appropriate PPE (Polovich & Martin, 2008,
February). The organizations’ commitment to safety may be an explanation for the
variability in availability of PPE and use of precautions. Organizations with a positive
safety climate both provide appropriate PPE and encourage its use.
Feedback and Reinforcement for Safety
Use of safety equipment is often associated with extra work effort, slower work
pace, and personal discomfort. Because of these barriers, reinforcement for the use of
safety equipment is necessary. Performance feedback is “social approval or disapproval
received from coworkers, supervisors and managers” for worker behavior (Dejoy,
Gershon et al., 2004, p. 51).
In an interrupted time-series study in an industrial setting, supervisors provided
regular safety-related interactions, showing approval for safe behavior and disapproval
for unsafe behavior (Zohar, 2002). This use of feedback resulted in significant changes in
the minor injury rate, the use of earplugs for hearing protection, and safety climate scores
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in the experimental group. Feedback has also been associated with a positive safety
climate and compliance with safety precautions by healthcare workers (Dejoy, Gershon et
al., 2004; Grosch, Gershon, Murphy, & DeJoy, 1999) and retail workers (Dejoy, Gershon
et al., 2004). In another study involving healthcare workers, peer feedback improved
handwashing and glove use for Thai healthcare workers (Moongtui, Gauthier, & Turner,
2000), although the results were not sustained. Gershon and colleagues (2000) found that
failure to provide safety-related feedback was related to increased workplace exposure
incidents. No studies have evaluated safety feedback in settings where HDs are handled.
Management Support of Safety
Management support for safety programs has been studied for over thirty years in
industrial settings; however this has not been well-studied in healthcare settings. DeJoy
suggests that if workers perceive that productivity is more important than safety
concerns, unsafe behavior is encouraged (Dejoy, 1986).
In a small qualitative study of five nurses with self-reported adverse health
outcomes following occupational HD exposure (Polovich & Minick, 2008), nurses
discussed barriers that existed in adopting HD safe handling precautions because of
characteristics of the organizations in which they worked. Lack of knowledge about the
risks of exposure by persons in authority and monetary issues affected the
implementation of HD safe handling programs. These nurses reported a general mistrust
of their employers related to worker safety and believed that lack of PPE, safety
procedures, and administrative support for HD safe handling programs contributed to
their HD exposure. They implied that if their employers had been more responsible, they
might not have experienced adverse health outcomes. Although the sample size was
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small, this study was the first to suggest the importance of safety climate in use of HD
safe handling precautions.
Characteristics of an organization are likely to influence individual worker’s
behavior related to health and safety. This concept is especially applicable to nurses who
practice as employees in a health care setting. Activities of organizations that encourage
safety include having safety goals, allocating resources for safety, having policies that
promote safety, and providing safety training. Gershon (1995) reported a significant (p <
.001) positive relationship between ‘perceived organizational commitment to safety’ and
UP compliance in hospitals and the findings have been consistent across healthcare
worker populations (Gershon et al., 2000; Gershon, Stone, Bakken, & Larson, 2004).
HPD use was predicted by positive “union climate” (Raymond et al., 2006) and
“supervisor climate” for non-Hispanic Whites (Hong et al., 2005; Raymond et al., 2006).
Lack of an organizational mandate for use of PPE was stated as a reason for
farmers’ failure to wear eye protection (Forst et al., 2006) and nurses’ failure to use
appropriate PPE for HD handling (Valanis et al., 1991). Nurses who reported double
gloving for HD handling were significantly more likely to practice in organizations that
had updated polices since NIOSH published this recommendation (X2(1) = 17.5, p <.01)
(Polovich & Martin, 2008, February).
Several studies have reported lack of availability of appropriate PPE for HD
handling (Martin & Larson, 2003; Polovich & Martin, 2008, February; Valanis &
Shortridge, 1987). Spill kit availability and use in the event of a HD spill was
significantly lower (p = .01) in physician private practice settings than in hospital
inpatient or outpatient settings (Polovich & Martin, 2008, February). Because both the
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availability and use of appropriate equipment and precautions varies by type of setting,
the organizations’ commitment to safety may be an explanation for this variability.
Interpersonal Influences on Protective Behavior
Interpersonal influence refers to the impact of important others’ attitudes toward,
support for and modeling of a particular behavior. Levin (1999) found that attitudes of
co-workers toward glove use did not influence glove use for potential blood exposure;
however, interpersonal influence was found to be a predictor of HPD use in several
studies (Hong et al., 2005; Kerr et al., 2002; Lusk et al., 1999; Lusk et al., 1997;
McCullagh et al., 2002). These studies indicate that workers are more likely to use
protective equipment if their co-workers do. In one study, modeling accounted for more
variance in HPD use by construction workers than any other predictor (Lusk et al., 1997).
Interpersonal influences have not been studied in the use of HD precautions. Perceived
Conflict of Interest
Health care workers may report a conflict between the need for self-protection
and the need to provide timely and safe patient care. This type of situational influence is
unique to health care when staff work closely with patients and when the exposure risks
are related to the patients themselves or to patient care. With respect to UP, workers who
reported high levels of conflict of interest were half as likely to be compliant with UP as
those who reported low conflict levels (Gershon et al., 1995). This kind of influence has
not been measured in HD handling, but was suggested in two studies. Nurses reported
that PPE use “might upset patients” (Valanis & Shortridge, 1987) or “interfere with
staff’s relationship with patients” (Valanis et al., 1991).
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Summary
This study addresses several gaps in the literature. First of all, although
researchers have measured how often nurses use HD safe handling precautions in many
studies over the last twenty years, very few studies have measured the impact of specific
factors on nurses’ use of HD safe handling precautions. All studies have been descriptive.
There have only been a few studies examining relationships between PPE use and
selected characteristics of nurses (age and experience) (Martin & Larson, 2003; Polovich
& Martin, 2008, February); characteristics of the workplace (type of setting and
geographical location) (Martin & Larson, 2003; Polovich & Martin, 2008, February); and
perceived risk (Martin, 2006). Therefore, the use of precautions has been welldocumented, but reasons for using or failing to use HD safe handling precautions have
not. This study examined theoretical predictor variables—knowledge of chemotherapy
exposure, perceived risk of harm from HD exposure, self efficacy for PPE use, and
perceived barriers to PPE use—and their relationship to the use of HD safe handling
precautions.
Safety climate, or employees’ collective perceptions about an organization’s
commitment to providing a safe work environment, is an important factor in the
occupational safety literature. However, this has never been explored in the area of HD
safe handling. This study examined the influence of this aspect of organizations on
nurses’ use of precautions.
Finally, the notion of a nurses’ need to choose between patient care and use of
safe handling precautions has been suggested, but not measured. This study evaluated
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perceived conflict of interest between protecting self and caring for patients as a potential
moderator of nurses’ use of HD safe handling precautions.
Since HD safe handling precautions will reduce nurses’ exposure to HDs, it is
essential to promote their use. This study provides important information about factors
that affect nurses’ decision to use HD safe handling precautions.

CHAPTER III
METHODOLOGY
This chapter describes the methods used in conducting the study. The following
sections are included: research design, sample and recruitment, data collection and
instruments, study procedures, data management and analysis plan, and methods used to
protect human subjects.
Research Design
A cross-sectional, correlational design was used to determine the relationships
among nurses’ use of HD safe handling precautions and knowledge about HD exposure,
perceived risk of harm from HD exposure, self-efficacy for using PPE, barriers to use of
PPE, organizational influences, interpersonal influences, and perceived conflict of
interest between protecting self and caring for patients. The interaction effect of nurses’
perceived conflict of interest (need to protect self vs. need to provide medical care) and
self-efficacy for PPE use and the use of HD safe handling precautions were also
examined. A mail survey method was used to reach nurses who are currently involved in
handling HDs. In addition, managers’ perspectives on use of safe handling precautions in
the workplace were explored using a semi-structured telephone interview.
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Sample and Recruitment
The participants for the study were registered nurses (RNs) who were employed
in oncology settings and who reported handling antineoplastic chemotherapy agents
(preparation, administration, disposal or handling contaminated excreta) in the previous
year. The exclusion criterion was reporting no chemotherapy handling in the last year.
Although a random sample is recommended for a correlational design, it was not feasible
for this study. The population of all U.S. nurses handling HDs was not easily identifiable.
Using a membership list from the Oncology Nursing Society [ONS] was not appropriate,
since it is estimated that only 50% of nurses involved in cancer care are members of ONS
(A. Stengel [ONS Membership Services], personal communication, December 3, 2007).
In order to include both members and non-members of ONS, oncology nurses were
identified through their places of employment, using a national sample frame.
Participants were selected from a membership mailing list purchased from the
Association of Community Cancer Centers (ACCC). Surveys were mailed to potential
participants. The Tailored Design Method (Dillman, 2007) was used to increase the
response rate, which includes multiple contacts with the questionnaire recipient by first
class mail, the use of a small incentive, stamped return envelopes, and a respondentfriendly survey. Participant characteristics were obtained, including demographic data,
years of experience in nursing, information about workplace characteristics, and
geographic location.
Another potential source of information about nurses’ use of safe handling
precautions is the manager or supervisor of nurses who handle HDs. Manager-
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participants identified themselves as holding a formal organizational position where part
of their responsibility included the supervision of nurses who handle chemotherapy.
Managers were also recruited by mail using the ACCC mailing list.
Sample Size
Required sample size was determined using G*Power (Faul, Erdfelder, Lang, &
Buchner, 2007). The recommended sample size was 159 participants. This was based on
performing multiple regression with the eight predictor variables in the conceptual model.
This sample size should result in sufficient power to detect a moderate effect size of the
model (power = .80, α = .05, effect size f2 = .10). To achieve the minimum sample size,
surveys were mailed to 320 nurses to account for non-response, with a target enrollment
of 160 nurses. In addition, 20 managers were recruited.
Data Collection and Instruments
In correlational studies, accurate measurement of variables is essential to the
validity of the results. Several strategies were used. Because several of the study
instruments measuring the variables were adapted from tools used with different
populations, the first step was to assess the validity and reliability of the questionnaires.
A content validity assessment (CVI) of the questionnaires measuring the predictor
variables (chemotherapy exposure knowledge, self efficacy for using PPE, perceived
barriers to using PPE, perceived risk of harm from HD exposure, and workplace safety
climate) was conducted using an online survey. Three consultants, two with expertise in
HD handling, and one with expertise in occupational safety and health, scored the
instruments using the following rating scale for each item: 1 = not relevant, 2 =
somewhat relevant, 3 = quite relevant, 4 = very relevant. Scores were dichotomized so
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that items scoring 1 or 2 were considered “not relevant” and those scoring 3 or 4 were
considered “relevant.” The CVI was calculated using the universal agreement method
(Polit, Beck, & Owen, 2007) for each item and each scale.
After the first assessment, several items were revised due to low item-CVI.
Following a second evaluation, all items had a CVI of 1.0, which Polit and colleagues
(2007) suggest is appropriate when five or fewer experts assess an instrument.
The instruments were pilot tested to evaluate them for internal consistency and
test-retest reliability with a non-random sample of 20 oncology nurses who handle HDs.
The surveys were administered twice, approximately two weeks apart, and a correlation
coefficient computed for the relationship between the scores. A Cronbach’s alpha
measure of internal consistency was also computed. Instruments measuring most of the
predictor variables performed well in the pilot study, with good to excellent internal
consistency (.72-.95) and test-retest reliability (.70-.92) (See Table 3).
The scale measuring chemotherapy exposure knowledge did not perform as well
in the pilot study. Internal consistency reliability was acceptable (α = .70), but test retest
reliability was only .35. Scores ranged from 10-12 in both rounds of the pilot study, but
several individuals improved their scores from time one to time two, resulting in the poor
test-retest reliability.
One item (“Reuse of disposable PPE makes me feel less protected”) was removed
from the Self Efficacy for Using PPE Scale based on low internal consistency in the pilot
study (Cronbach’s Alpha = .67). Removing that item from the analysis improved the
internal consistency (α = .83) and test-retest reliability of the scale (R = .69). Because of
the small number of participants in the pilot study, the item was retained for the larger
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study, with the intent to evaluate its reliability with a larger sample size. Reliability of the
7-item scale improved, but remained higher with the six items (α = .79 and .86,
respectively). Therefore, results from the six-item scale were used for hypothesis testing
in the final study. An overview of the revised instruments is provided in Table 2. Pilot
study results are presented in Table 3. The complete study instruments are found in
Appendix A.
Table 2
Overview of Study Instruments
Variables

Instrument

# Items / Scoring

Interpretation

Outcome Measures:
Safe
Handling
Precaution
Use

Revised Hazardous
Drug Handling
Questionnaire

Predictor Variables:
Knowledge of
Chemotherapy
the Hazard
Exposure
Knowledge

Self Efficacy

Self-efficacy for
Using PPE

Preparation: 6 items
Administration: 5 items
Disposal: 5 items
Excretion: 6 items
0 = never to 5 = always
Total precautions (Mean
score for Admin +
Disposal) Range 0-5

Higher score
indicates
higher use of
safe handling
precautions.

12 items: True, False,
Don’t know.
Items 3, 6, 8, 9, 11 are
false; all others true.
Correct answers=1, all
others = 0.
Range: 0-12 (Sum)
6 items, 1 = strongly
agree to 4 = strongly
disagree. Items are
reverse-scored
Range: 6-24 (Sum)

Higher score
indicates
higher
knowledge

Higher score
indicates
higher self
efficacy
(Table 2 Continues)
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(Table 2 Continued)
Variables
Perceived
Barriers

Instrument
Barriers to Using
PPE

# Items / Scoring
13 items, 1 = strongly
disagree to 4 = strongly
agree.
Range: 13-52 (Sum)

Perceived Risk

Risks of
Chemotherapy
Exposure

Organizational
Influences

Workplace Safety
Climate

Perceived
Conflict of
Interest

Conflict of
Interest Scale

Interpersonal
Influences

Interpersonal
Norms

3 items, 1 = strongly
disagree to 4 = strongly
agree. Items are
reverse-scored.
Range: 1-4 (Mean)
21 items, 1 = strongly
disagree to 5 = strongly
agree
Range: 21-105 (Sum)
6 items, 1 = strongly
disagree to 4 = strongly
agree.
Range: 6-24 (Sum of
items)
4 items, importance to
others of using PPE,
0 = not at all,
1 = sort of, 2 = a lot
Range: 0-2 (Mean)

Interpersonal
Modeling

3 items, frequency of
others’ use of PPE,
0 = never to 3 = usually
Range: 0-3 (Mean)

Interpretation
Higher score
indicates
higher
perceived
barriers
Higher score
indicates
higher
perceived
risk
Higher score
indicates
better safety
climate
Higher score
indicates
higher
conflict of
interest.
Higher score
indicates
higher belief
that others
think PPE is
important.
Higher score
indicates
higher use of
PPE by coworkers.
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Table 3
Pilot Study Results: Total Scale Scores, Cronbach’s Alpha and Test-Test Reliability for
Predictor Variables
Scale

M (SD)

Range

Chemotherapy
Exposure
11.2 (.77)
0-12
Knowledge
Self Efficacy For
22.9 (3.31)
6-24
Using PPE
Barriers to Using PPE
25.6 (5.83)
13-52
Risks of
Chemotherapy
3.16 (.54)
1-6
Exposure
Workplace Safety
81.2 (16.89) 21-105
Climate
Conflict of Interest
11.9 (4.18)
6-24
Scale
Interpersonal
1.9 (.58)
0-3
Influence
Note. Time 2 data collected 2 weeks after Time 1

Observed
Range

Cronbach’s
Alpha

Correlation
Coefficient
T1 - T2*

10-12

.70

.35

11-24

.83

.70

13-37

.77

.72

2-4.5

.72

.78

52-105

.95

.86

6-21

.89

.70

.57-2.5

.91

.92

Safe Handling Precautions Use
Nurses’ use of HD safe handling precautions was measured by the Revised
Hazardous Drug Handling Questionnaire. It is a survey developed by Martin and
Larsen (2003) and adapted by Polovich and Martin (2008, February). It is based on the
current guidelines for the handling of HDs (NIOSH, 2004). Following the pilot study, the
instrument was further revised so that items measuring the use of protective equipment
were changed from a 3-point scale (usually, occasionally, rarely) to a 5-point scale in
order to capture additional variability. Additional items were added to distinguish
between nurses’ use of chemotherapy-designated PPE and other types of PPE. For
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example, use of “other gloves” and “other gowns” (e.g. not tested for use with
chemotherapy) were added.
The final instrument included 25 scored items, which are Likert-type items that
indicate the frequency of PPE use (5 = Always, 4 = 76-99%, 3 = 51-75%, 2 = 26-50%, 1
= 1-25% and 0 = Never) for various handling activities. An example is “Please indicate
how much of the time you use the following when administering hazardous drugs: gloves
labeled for use with chemotherapy.” Higher mean scores indicate higher use of safe
handling precautions. Mean scores were determined for safe handling practices and PPE
use for all handling activities, including drug preparation, drug administration,
chemotherapy disposal, and handling of excreta. Additional items collected information
such as the availability of PPE, spill kits, and safe handling policies.
Knowledge, Self-Efficacy, Barriers and Perceived Risk
Three subscales from the Occupational Dermal Survey, the knowledge, selfefficacy, and barriers subscales, and three items about perceived risk (Geer et al., 2007;
Geer et al., 2006) were used. They were originally developed for dermal chemical
exposure in the industrial setting, and were adapted for HD exposure in healthcare
settings. This survey was initially developed based on a literature review of factors
influencing protective behaviors for dermal chemical exposure. Content validity was
demonstrated using a panel of experts in industrial hygiene, PPE and survey design. Two
focus groups of industrial employees who work with chemicals reviewed the instrument
for face and content validity, and then the scale was pilot tested (Geer et al., 2006).
The Chemotherapy Exposure Knowledge scale consists of 12 items with the
response options of true, false, and do not know. Correct answers are scored 1 point and
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all others are scored 0. The possible range of scores is 0-12. This scale had a Cronbach’s
alpha of .70 in the final study.
The Barriers to Using PPE scale is a 13-item Likert scale with four response
options: 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree. Item
scores are summed and higher scores indicate higher perceived barriers to PPE use.
Scores have a possible range of 13-40. Cronbach’s alpha was adequate (.77 in the pilot
and .88 in the larger study).
The original survey had two items about perceived risk. The adapted scale
included six items about perceived risk, which performed well in the pilot study
(Cronbach’s alpha = .72, test-retest .78). However, in the larger study, only three items
had good internal consistency reliability (Items 5, 6, and 7). Each was scored 1 = strongly
disagree, 2 = disagree, 3 = agree, and 4 = strongly agree, and reverse scored so that
higher scores mean higher perceived risk. Mean scores have a possible range of 1-4.
Cronbach’s alpha for the 3-item Risks of Chemotherapy Exposure scale was .70.
Organizational Influence and Perceived Conflict of Interest
Two subscales of the Healthcare Worker Questionnaire (Gershon et al., 1995;
McGovern et al., 2000) were adapted for HD exposure for this study. These subscales
were the Workplace Safety Climate (WSC) questionnaire and the Conflict of Interest
Scale. The Healthcare Worker Questionnaire was developed to measure compliance with
UP among HCWs at risk for occupational exposure to bloodborne pathogens. It has been
used in several different settings, including hospitals, correctional facilities, and nonhospital based healthcare facilities (Gershon et al., 2005; Gershon, Qureshi et al., 2007;
Gershon, et al., 1995). Factor analysis was used to assess the construct validity of the

50
Workplace Safety Climate (WSC) scale. It was tested with a sample of 789 hospitalbased healthcare workers. Six organizational dimensions were determined. These are 1)
PPE and engineering control equipment availability, 2) management support, 3) absences
of job hindrances, 4) feedback and training, 5) cleanliness and orderliness, and 6)
minimal conflict/ good communication. Minor changes were made to items to adapt them
for HD handling (e.g. “chemicals” changed to “chemotherapy”). The items are scored 1 =
strongly disagree to 5 = strongly agree (Gershon et al., 2000). Item scores are summed for
a total WSC score. The potential range of scores is 21-105, with higher scores indicating
a better safety climate. The scale was found to have adequate internal consistency in the
final study (α = .93).
Conflict of interest was measured using a 6-item scale adapted from a 4-item
subscale of the Healthcare Worker Questionnaire. This subscale was originally a part of
the “barriers to UP compliance” scale. Gershon (1995) reported that the reliability of the
4-item scale was (α = .72) in a study of HCWs’ use of UP. The reliability of the adapted
scale was adequate (α = .89) in both the pilot study and the larger study.
Interpersonal Influences
Interpersonal influences in the workplace, the impact of others on PPE use, was
measured using an instrument adapted from McCullagh (McCullagh et al., 2002). The
instrument measures two aspects of interpersonal influences, interpersonal norms and
interpersonal modeling. Four items measure a person’s beliefs regarding how much
others (e.g. co-workers, supervisors) think they should use PPE. Response options are 0 =
not at all, 1 = sort of, 2 = a lot. Three items measure how often other nurses use
protective equipment (0 = never to 3 = usually). Higher scores indicate a more positive
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view of co-worker’s attitudes towards and use of PPE. Mean scores from the two scales
are combined to obtain an Interpersonal Influence score. Internal consistency reliability
of the original norms and modeling scales was .75 & .68 with farmers (McCullagh et al.,
2002) and .76 & .86 (Lusk et al., 1997) with construction workers. Reliability of the
interpersonal influence scale as adapted for HD handling was .91 in the pilot and .80 in
the larger study.
Managers’ Perspectives
The WSC Questionnaire was administered to the managers with instructions that
they answer items like they thought the nurses they supervise would answer. Managers
provided additional data through a telephone interview about the safety climate in their
workplace and the barriers to use of HD safe handling precautions by nurses. The guide
used for the semi-structured interview is in the Appendix.
Procedures
Instrument evaluation and data collection for the study began after obtaining
approval from the Georgia State University Institutional Review Board. An address list
was purchased from the Association of Community Cancer Centers. Three hundred nine
members who identified themselves as nurses were selected for the nurse participant part
of the study after sorting the list by state. Surveys were sent with a cover letter describing
the importance of the study and urging nurses to participate. A token of appreciation, a
$5.00 gift card, was included as an incentive. A pre-addressed, stamped envelope was
provided for the return of the study instruments. Surveys were labeled with identification
(ID) numbers linking them to the address of the recipient. This number was used only to
track responders to identify non-responders for subsequent mailings. A thank-you
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postcard was sent approximately one week after the original survey, encouraging them to
respond soon. When surveys were returned, names and addresses were removed from the
mailing list. Originally, there were to be multiple mailed reminders to the potential
participants. However, the organization providing the mailing list rented the list for single
use only. Due to budget limitations, only two mailings per participant were done.
Additional members were selected from the original list to reach the planned accrual
goal.
In addition to the paper study instruments, the questionnaire was made available
electronically using a secure version of an online survey service. A web address was sent
in the initial mailing with a link to the online survey.
Nurse surveys were returned to a post office box obtained for the study. A
researcher retrieved the surveys from the post office box several times per week during
the study period. The researcher recorded receipt of the survey by the ID number and
deleted the participants’ name and address from the mailing list.
Managers’ Perspectives
Fifty-two members with titles that indicated they held manager or director
positions were selected from the mailing list for the manager part of the study. Fifty were
included in the initial mailing, and 2 additional were mailed to meet the accrual goal of
20. A cover letter explaining the importance of the study and encouraging them to
participate was sent. A token of appreciation, a $5.00 gift card, was included as an
incentive. A pre-addressed, stamped envelope was provided for a response card that
indicated interest in participating. A web address was sent with a link to a website as an
alternate way to respond. Letters and response cards were labeled with ID numbers
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linking them to the address of the recipient. This number was used only to track
responders to identify non-responders for subsequent mailings. The first fifty potential
manager participants were also sent an envelope with a nurse survey and gift card, with a
request that they give it to a nurse who handled chemotherapy in their workplace. A
thank-you/reminder postcard was sent approximately one week after the original mailing.
Managers who responded by either mail or online were contacted by a member of
the research team to schedule a telephone interview. Using telephone interviews rather
than face-to-face interviews is more cost effective, less time-consuming, allows for
including study participants from wide geographic areas (Waltz, Strickland, & Lenz,
2005) and reduces item non-response (Dillman, 2007). Since this plan was to include a
sample of managers from across the nation, telephone interviews were the most
appropriate data collection method.
Interviews were conducted using a semi-structured format, with both closed- and
open-ended questions. One part of the interview included verbal administration of the
WSC Questionnaire. Additional open-ended questions were used to elicit more detailed
information about the concepts of interest. An d was developed to structure the interview
to encourage each manager-participant to provide an answer to all of the questions. This
reduced missing data.
A research assistant served as interviewer and was trained prior to conducting the
interviews. An interview guide was used that included introductory information,
complete instructions, the questions, and closing statements. The order of the questions
was the same for all participants. Probes were provided as needed to encourage complete
responses. Interviews were audio recorded for accuracy with the consent of the
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participants. Most interviews were completed in approximately 30 minutes. They were
scheduled at a time that was convenient to the participants.
Data Management Plan
A code book was developed to direct data entry and to determine how ambiguous
data should be recorded. Data were double-entered, and compared for accuracy. A
research assistant entered data into Excel, and the data were imported into Statistical
Package for Social Sciences (SPSS) 17.0 (SPSS Inc., 2008). The original paper surveys
will be retained for at least one year after completion of the data analysis. Back-up files
of the data were made and stored after each data entry session. The final copy of the raw
data will be kept by the researcher indefinitely.
The recorded interviews were transcribed verbatim using a transcriptionist. The
answers to the open-ended questions comprised the text for the content analysis.
Data Analysis
Data were double entered by two members of the research team, compared for
accuracy, and errors corrected. Data analysis began with standard data cleaning
procedures. Patterns of missing data were determined. Missing data from predictor
variables (barriers, self efficacy, workplace safety climate, conflict of interest, and
interpersonal influence) were replaced with the participant scale mean only when less
than 20% of the total scale data were missing. No missing data were replaced for the
knowledge scale. Missing data from the outcome variable was replaced with the sample
mean only when less than 20% of total scale data were missing. The reliability of the
instruments was evaluated. Prior to hypothesis testing, data were assessed for normality,
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outliers, and other assumptions of adequate variance, lack of multicolinearity, and
homoscedasticity.
Descriptive statistics were used to characterize the distribution of the variables
and the characteristics of the sample. Frequencies, means and standard deviations were
determined for all continuous variables. Correlations were computed among the set of
variables. A significance value of .05 was used for all statistical analyses.
Analysis for Specific Aims
The following section contains the approach to statistical analysis based on the
study questions and hypotheses.
Specific Aim 1: Determine the influence of individual and organizational factors
on nurses’ use of safe handling precautions for nurses exposed to HD in their practice.
Hypothesis 1a: Nurses’ individual characteristics (higher knowledge, higher
perceived risk of harm from HD exposure, higher self-efficacy for using PPE and fewer
perceived barriers to using PPE) will be associated with an increased use of HD safe
handling precautions. Spearman’s correlation coefficient was computed for the
relationships between use of precautions and chemotherapy exposure knowledge,
perceived risk, self efficacy and perceived barriers. Significant correlations in the
expected direction support the hypothesis. A negative relationship between perceived
barriers and precaution use was expected; all other relationships are positive.
Hypothesis 1b: Organizational factors (better workplace safety climate and
interpersonal influences) will be associated with increased use of safe handling
precautions. Spearman’s correlation coefficient was computed for the relationships
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between use of precautions, safety climate, interpersonal norms and interpersonal
modeling. Positive, significant correlations support the hypothesis.
Hypothesis 1c: Nurses’ individual characteristics (higher knowledge, higher
perceived risk of harm from HD exposure, higher self-efficacy for using PPE, fewer
barriers to using PPE) and organizational factors (better workplace safety climate and
interpersonal influences) will each account for significant variance in use of safe handling
precautions. Hierarchical multiple regression was performed with the individual
predictor variables entered, followed by the organizational variables and examining for a
significant change in R2.
Research Question 1d: Does nurses’ perceived conflict of interest (need to protect
self vs. need to provide medical care) moderate the relationship between self-efficacy and
use of safe handling precautions? Using hierarchical regression, in the first step, the
predictor variables were entered. In the second step, an interaction term for self efficacy
and conflict of interest was entered. A significant change in R2 for the interaction term
supports the hypothesis.
Secondary Aim
To determine nurse managers’ perspectives on use of safe handling precautions in
the workplace, both interview data and questionnaire data were analyzed. For interview
data, a content analysis was used, in which the major categories of interest were derived
from the theoretical model for the study. These were knowledge, self-efficacy, safety
climate, perceived barriers, perceived risk, interpersonal influence, perceived conflict of
interest and safe handling precautions. The categories derived from the concepts were
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defined so that words and phrases could be coded to belong to only one category.
Categories were added as needed based on the data.
To answer research question 2a (nurse managers’ perceptions of the
organizational climate for safe handling precautions), manager’s responses on the WSC
Questionnaire were analyzed in addition to interview data.
Protection of Human Subjects
This study involved nurses who are involved in the preparation or administration
of hazardous drugs or the care of patients receiving hazardous drugs. The protocol, cover
letter, manager consent, other correspondence and study instruments were approved by
the Georgia State University Institutional Review Board (IRB).
Participants received a token of appreciation with the study instruments as an
incentive to participate. This was a $5.00 gift certificate to a general store (Wal-Mart).
Risks to Subjects
Human Subjects Involvement and Characteristics
All study participants were RNs age 18 and over who are employed in an
oncology setting and who report handling antineoplastic chemotherapy agents
(preparation, administration, disposal or handling contaminated excreta) in the previous
year. Participants were recruited by mail.
Sources of Data
The data obtained by this study was limited to nurse-participant responses to
questionnaire items. To ensure confidentiality, no survey data contained names or
personal identifiers. No protected health information was obtained. The completed
surveys were mailed to a secure post office box. Twenty subjects completed the survey
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instruments using a secure version of an online survey service. Responses were
transferred from the paper questionnaires and the online survey to a computer file. All
survey materials were secured and available only to the research team. (Note: The
research team consists of the PI, the co-investigator, the research assistant, and the
transcriptionist).
Managers’ data were collected by telephone interview. Interviews were audio
recorded with the consent of the participants. Participants were reassured that any
information provided during the interview will be kept confidential. No identifiers were
used that could connect the participants with their data. Recorded interviews and
transcriptions were stored in a secure location in the researchers’ office. Recordings were
not available to anyone other than the research team.
Potential Risks
There were no known risks associated with participation in the survey.
Involvement required about 15-20 minutes of time to complete the survey instruments.
Providing information about their employer or place of employment may have been
concerning to some participants. The cover letter assured the participants that they were
free to stop the survey at any time or to skip any question for any reason.
There were no known risks associated with the managers’ participation in the
interview. Involvement required 30-60 minutes of time. Providing information about their
place of employment may have been concerning to some participants. The consent form
assured the managers that they were free to stop the telephone interview at any time or
not respond to any question for any reason.
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Adequacy of Protection against Risks
Data collection did not begin until IRB approval was obtained. In a cover letter
sent with the survey instruments, prospective nurse-participants were informed of the
study purpose, procedures, risks and benefits, confidentiality, and where to get more
information. Participation in the study was strictly voluntary. Completing and returning
the survey instruments constituted consent. Unique identification numbers were used
only to track responders and non-responders for subsequent mailings. Names and
addresses of participants were deleted from the mail list when surveys were returned. All
data were entered without identifying information. The research assistant was instructed
in confidentiality procedures related to handling of questionnaires.
For the managers, a consent form was sent to potential participants, which they
were directed to keep for their records. Verbal consent was obtained by telephone before
the interview, and participation in the interview constituted consent.
Potential Benefits of the Proposed Research to the Participants and Others
Participants received no direct benefit from participating in this study other than
the token incentive and knowledge of their contribution to information about the factors
that influence nurses’ use of HD safe handling precautions.
With a better understanding of the factors that influence nurses’ use of HD safe
handling precautions, new strategies to improve nurses’ workplace safety related to
handling HDs may be developed.

CHAPTER IV
RESULTS
This chapter presents the results of this cross-sectional, correlational study to
determine the relationships among nurses’ use of HD safe handling precautions and
several theoretical predictor variables (knowledge, self efficacy for PPE use, barriers to
PPE use, perceived risk of harm from HD exposure, interpersonal influence, workplace
safety climate, and conflict of interest); and managers’ perspectives on the use of HD safe
handling precautions by nurses in their workplace. A description of sample characteristics
and results of hypotheses testing are reported.
Study Response Rate
Surveys were mailed to nurses from the ACCC mailing list. The overall response
rate was 46%. Figure 2 provides details about the nurse survey response.
Mailed Surveys
(N = 359)

Excluded (n = 34)
Returned, undeliverable
n = 19 (5%)
Not meeting inclusion criteria
n = 15 (4%)

Not Returned
n = 160 (45%)

Returned
n = 165 (46%)

Figure 2. Response Rate for Nurse Participants
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Nurse Participants
The majority of nurses were White, female and middle-aged, although ages
ranged from 23-70 years. Most nurses were very experienced in nursing, oncology
nursing and chemotherapy handling, reported being an ONS member, and were certified
in oncology nursing. Most nurses reported practicing in outpatient settings. Nurses
reported a wide range (0-400) of number of patients receiving chemotherapy per day in
their practice setting (M = 25.0, Mdn = 18, SD = 35.2), and the average number of
patients for whom they personally handled chemotherapy per day as = 6.8 (Mdn = 6.0,
SD = 5.2). Table 4 summarizes the descriptive statistics for characteristics of nurse
participants in the study.
Table 4
Nurse Characteristics (n = 163)
Characteristic
Age (years)
Gender
Female
Male
Experience (years)
Nursing
Oncology
Chemotherapy
ONS Member (n = 162)
Yes
No
Nursing Certification (n = 159)
Not certified
Oncology (OCN, Advanced Oncology)
Other

M
(SD)
46.4 9.26

n

(%)

160 (98.2)
3 (1.8)
21.2 (9.25)
15.8 (7.59)
15.2 (7.62)
140 (86.4)
22 (13.6)
21 (13.2)
136 (85.5)
2 (1.3)
(Table 4 Continues)
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(Table 4 Continued)
Race / Ethnicity
White
American Indian/Alaskan Native
Asian
Black/African American
Hispanic/Latino
Multi-cultural
Unspecified
Highest Level of Nursing Education
Diploma
Associate Degree
Bachelor’s Degree
Masters Degree
Doctoral Degree
Geographic Location (n = 165)
Northeast
Southeast
Midwest
Southwest
West
Type of Setting
Inpatient
Outpatient
Both
Type of Facility
Academic health center
Community non-teaching hospital
Community teaching hospital
Private physician office
Public/government hospital
Other
Treatment Volume
Number of patients per nurse
Number of patients per practice setting
Note: n varied due to missing data.

139
2
7
7
2
4
2

(85.3)
(1.2)
(4.3)
(4.3)
(1.2)
(2.5)
(1.2)

12
49
76
24
2

(7.4)
(30.1)
(46.6)
(14.7)
(1.2)

43
40
47
10
25

(26)
(24.2)
(28.5)
(6.1)
(15.2)

24
112
27

(14.7)
(68.7)
(16.6)

7
56
36
46
9
9
M (SD) Range
6.8 (5.2)
0-35
25 (35.2) 0-400

(4.3)
(34.4)
(22.1)
(28.2)
(5.5)
(5.5)
Mdn = 6
Mdn = 18

Manager Participants
The desired sample of 20 managers was obtained by mailing fifty-two letters of
invitation to managers selected from the ACCC mailing list. Figure 3 provides details
about the response rate for manager participants.
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Mailed Letters
n = 52

Returned, undeliverable
n = 2 (4%)
Not meeting inclusion criteria
n = 2 (4%)

No Response
n = 28 (54%)

Interviewed
N = 20 (38%)
Figure 3. Response Rate for Manager Participants
One manager was a radiation therapist and the others were nurses. The
majority of managers were White, female and middle-aged, although ages ranged from
30-70 years. They held titles of manager, director, and supervisor, and two identified
themselves as clinical nurse specialists with management responsibilities. Managers were
generally experienced in their role (1-29 years), had up to 49 years of nursing experience
and were responsible for 10-300 employees (M = 55.6, SD = 63.2, Mdn = 44.5). The
majority of managers worked in outpatient settings (80%) where between 2 and 450
patients received chemotherapy per day (M = 61, SD = 108.5, Mdn = 30). Table 5
summarizes the descriptive statistics for characteristics of manager participants in the
study.
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Table 5
Manager Characteristics (n = 20)
Characteristic
M
Age (years)
48.8
Gender
Female
Male
Experience (years)
Manager role
9.0
1
Nursing
22.4
Race / Ethnicity
White
American Indian/Alaskan Native
Black/African American
Other/No response
Geographic Location
Northeast
Southeast
Midwest
Southwest
West
Type of Setting
Inpatient
Outpatient
Both
Type of Facility
Academic health center
Community non-teaching hospital
Community teaching hospital
Private physician office
Treatment Volume
Patients per day
61.0
(workplace)
Min/Max = Observed minimum/ maximum
1
One participant was not a nurse

(SD)
(10.2)

(8.8)
(11.8)

(104.3)

Min/Max

n

(%)

19
1

(95)
(5)

16
1
1
2

(80)
(5)
(5)
(10)

6
3
6
3
2

(30)
(15)
(30)
(15)
(10)

4
12
4

(20)
(60)
(20)

2
10
6
2

(10)
(50)
(30)
(10)

1-29
0-49

2-450

Mdn = 30

Descriptive Statistics for Major Study Variables
Prior to addressing the hypotheses, data were examined for normal distribution,
presence of outliers, and missing data. None of the results from the theoretical predictor
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variables were normally distributed. Results for the Barriers scale and Conflict of Interest
scales were positively skewed. The results for the following variables were negatively
skewed: Knowledge scale, Self-Efficacy scale, Perceived Risk scale, Workplace Safety
Climate scale, Interpersonal Influences scale. Data transformation did not improve the
distribution. The outcome variable results were normally distributed without outliers.
Theoretical Predictor Variables
Table 6 displays the results of all of the instruments measuring the theoretical
concepts, including chemotherapy exposure knowledge, self efficacy for using PPE,
barriers to using PPE, perceived risk of harm from HD exposure, interpersonal influence,
conflict of interest, and workplace safety climate.
Table 6
Descriptive Statistics for Theoretical Predictor Variables
Variable

Observed Possible Cronbach’s
Range
Range
Alpha

M

(SD)

10.9

(1.07)

7-12

0-12

.70

20.8

(2.96)

12-24

7-24

.79

Perceived Barriers

21.94

(6.50)

13-40

13-52

.88

Perceived Risk

3.14

(.58)

1.6-4

0-4

.72

Interpersonal Influence

2.21

(.44)

.5-3

0-3

.80

Conflict of Interest

1.83

(.62)

1-3.5

1-4

.89

Workplace Safety Climate

88.39 (12.03)

60-105

21-105

.93

Chemotherapy Exposure
Knowledge
Self Efficacy for using PPE

Knowledge of the Hazard
Total scores on the Chemotherapy Exposure Knowledge scale ranged from 7-12
(M = 10.9, SD = 1.07), indicating that most nurses were fairly knowledgeable about
chemotherapy exposure. The three scale items that nurses lacked knowledge about were:
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“A surgical mask provides protection from chemotherapy aerosols” [false] for which
40% of nurses answered incorrectly; and “Chemotherapy cannot enter the body through
contact with contaminated surfaces [false], and “Alcohol hand sanitizer is as effective as
soap and water in removing chemotherapy residue” [false] which were each answered
incorrectly by 15% of respondents.
Nurses reported high self efficacy for using PPE (M = 20.8, SD = 2.96), and
moderate barriers to using PPE for HD handling. Four individual items on the barriers
scale had mean scores at or above the midpoint of the 0-4 scale. These included the
following items: PPE is uncomfortable (M = 2.4, SD .95); PPE makes me feel too hot (M
= 2.6, SD 1.0); PPE interferes with job (M = 2.0, SD = .87); and others do not use PPE (M
= 2.0, SD = .97).
On average nurses perceived high risk of harm from HD exposure with a mean of
3.14 on a 4 point scale. Nurses generally reported a low conflict of interest between the
need to protect themselves and care for patients while handling chemotherapy.
Based on the Interpersonal Influence scales, nurses perceived that co-workers
valued and used HD precautions when handling chemotherapy (M = 2.21, SD = .44).
Nurses rated their employing organization’s commitment to safety high, with an average
total score of 88.4 (SD = 12.03) on the WSC Questionnaire.
Nurses’ Use of Safe Handling Precautions
In the initial data analysis for the use of safe handling precautions two major
issues were identified. First, not all nurses participated in all aspects of HD handling and
the instrument for safe handling had a low reliability coefficient.
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In this sample not all nurses reported all handling activities. Most nurses reported
that they administered HDs (99%, n = 164) and disposed of HDs (93%, n = 154), but
only 73% (n = 120) handled excreta and 19% (n = 32) prepared HDs. In order to have a
sufficient sample size for hypothesis testing, the main outcome variable, total HD safe
handling precautions, was measured using the scales for administration and disposal.
Data related to the use of HD safe handling precautions for the preparation and handling
of contaminated excreta scale are reported descriptively but not included in the total HD
safe handling score.
To address the second problem of the low reliability coefficient (Cronbach's alpha
<.60), the scale reliability data were examined. To improve internal consistency, items
with the lowest item-to-total correlations were removed one by one, until an acceptable
reliability was obtained. The items with the lowest item to total correlations were closed
system transfer devices, “other gloves” (non-chemotherapy labeled) “other gowns” and
re-use of disposable gowns. The 5 items remaining in each of the administration and
disposal scales (10 items total) were related to use of chemotherapy gloves, double
gloves, chemotherapy gowns, eye protection and respirators. The internal consistency
reliability for these 10 items was adequate, with α = .83. The mean score for these 10
items was used for the hypothesis testing. Five items make up the mean score for the
excreta scale, and six items make up the mean score for HD preparation scale (the 5
above, plus use of biological safety cabinet). These data are reported descriptively.
As stated above, the total HD precaution use score was defined as the mean score
for use of chemotherapy gloves, double gloves, gowns, eye protection and respirators for
HD administration and disposal. Total HD precaution use was 1.9 (SD = 1.1). The
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possible range of scores was 0-5, with an observed range of 0-5. Table 7 and 8
summarize safe handling precaution use during the four HD handling activities.
Table 7
Means Scores and Standard Deviations for Nurses’ Use of Safe Handing Precautions
during Various HD Handling Activities
Preparation

Administration

Disposal

N = 32
M (SD)

N = 164
M (SD)

N = 154
M (SD)

Handling
excreta
N = 120
M (SD)

BSC

4.8 (.87)

-

-

-

Gloves

4.6 (1.2)

4.0 (1.7)

3.8 (1.9)

2.9 (2.3)

Double Gloves

1.0 (1.7)

1.2 (1.9)

1.1 (1.8)

1.3 (1.8)

Gowns

3.5 (1.9)

3.0 (2.2)

2.9 (2.2)

1.9 (2.1)

Eye Protection

1.5 (2.0)

1.3 (1.7)

1.0 (1.6)

1.2 (1.8)

Respirator

.58 (1.1)

.61 (1.1)

.59 (1.2)

.67 (1.4)

Overall
2.7 (.76)
2.0 (1.1)
1.9 (1.2)
1.6 (1.3)
Precautions
Response options: 0 = Never; 1 = 1-25%; 2 = 26-50%; 3 = 51-75%; 4 = 76-99%;
5 = Always. Possible range = 0-5
Table 8
Nurses Reporting Use of HD Precautions ‘Always’ or 76-99% of the Time
Precaution

Preparation Administration Disposal Handling Excreta
N = 32
N = 164
N = 154
N = 120
n (%)
n (%)
n (%)
n (%)

Biological Safety Cabinet

31 (97)

-

-

-

Chemotherapy Gloves

29 (90)

128 (78)

114 (74)

66 (55)

Double gloves

4 (12)

31 (19)

28 (18)

22 (18)

Chemotherapy Gowns

20 (64)

92 (56)

82 (53)

36 (30)

Eye protection

8 (25)

28 (17)

18 (12)

20 (17)

Respirator/mask

2 (6)

7 (4)

8 (5)

11 (9)
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Approximately one-fifth of nurses reported that they are responsible for
chemotherapy preparation. All of these nurses worked in outpatient settings, and most of
them (n = 27) worked in private physician offices. HD safe handling precaution use was
high for biological safety cabinets and chemotherapy gloves. Gown use was low and very
few nurses used double gloves, eye protection or respirators for drug preparation.
Glove use was high for all handling activities except for handling excreta. Gown
use was low for all handling activities. Double gloves, eye protection and respiratory
protection were rarely used by nurses in this sample. Overall precaution use was highest
for HD preparation (M = 2.7, SD = .76) and lowest for handling HD contaminated excreta
(M = 1.6, SD = 1.3).
Relationships Among Nurse Characteristics, Organizational Characteristics, and
Use of Safe Handling Precautions
Bivariate correlations were evaluated. Because of the non-normal variable
distributions, Spearman rank correlation coefficients (rs) were calculated and are reported
in Tables 9 and 10. Chemotherapy exposure knowledge was not associated with any
nurse characteristics or organizational characteristics. Higher self efficacy for PPE use
was associated with more years of nursing and chemotherapy experience, higher
perceived risk of harm from HD exposure, higher interpersonal influence (co-workers
valued and used precautions), better workplace safety climate, lower conflict of interest
and fewer barriers. Fewer barriers to safe handling practices were associated with lower
conflict of interest, higher self efficacy for PPE use, higher perceived risk of harm from
HD exposure, higher importance of PPE and use of PPE by co-workers, fewer patients
per day per nurse, and better workplace safety climate. Lower perceived risk of harm
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from HD exposure was associated with more years of chemotherapy experience. Higher
perceived risk of harm from HD exposure was associated with higher importance of PPE
and use of PPE by co-workers, lower conflict between the need to protect self and care
for patients, and better workplace safety climate. Lower conflict of interest between the
need to protect self and care for patients was associated with more years of oncology and
chemotherapy experience, higher importance of PPE and use of PPE by co-workers, and
better workplace safety climate.
The correlations among nurse characteristics and the theoretical predictor
variables are displayed in Table 9 and correlations among the theoretical predictor
variables in Table 10.
Table 9
Relationships among Nurse Characteristics, Theoretical Predictor Variables, and Total
HD Precaution Use
Chemotherapy
Exposure
Knowledge

Self
efficacy

Barriers

Risk

Interpersonal
influence

Conflict
of
interest

Total HD
Precaution
Use

.15

.14

-.50

-.06

.00

.01

.06

.03

.21**

-.09

-.11

.10

-.08

.03

.03

.29**

-.13

-.15

.13

-.17*

.06

Chemotherapy
experience1

-.00

.29**

-.14

-.17*

.14

-.19*

.08

Patients per
day (per
nurse)

.03

-.11

.23**

-.04

-.08

.16

-.28**

Age
Nursing
experience1
Oncology
experience1

rs = *p < .05, **p < .01
1
Experience in years

(2-tailed)
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Table 10
Relationships among Theoretical Predictor Variables
Knowledge

Self
efficacy

Barriers

Risk

Conflict of
interest

Interpersonal
influences

Knowledge
Self efficacy

.03

Barriers

-.04

-.62**

Risk

.13

.24**

-.38**

.07

-.52**

.68**

-.29**

-.08

.43**

-.51**

.13*

-.36**

.07

.67**

-.65**

.19**

-.58**

Conflict of
interest
Interpersonal
influences
Workplace
safety
climate
*
rs =
p < .05,

**

p < .01

.40**

(1-tailed)

Hypothesis Testing
There were no significant relationships between total HD safe handling precaution
use and nurse characteristics, including education level (F (4,158) = .953, p = .44), age (rs =
.06), nursing experience (rs = .03), oncology experience (rs = .06), and chemotherapy
experience (rs = .08). Safe handing precaution use was significantly different based on
facility type. Nurses in private physician offices personally handled chemotherapy for an
average of 10.7 (SD = 6.0) patients per day compared to 4.5 – 5.0 (SD = 2.9-3.7) patients
per day in other types of facilities. Analysis of variance and post hoc testing
demonstrated that the mean patients per day was significantly higher in private physician
office settings (F (5,152) = 11.8, p <.01). Because there was a relationship between higher
number of patients per day per nurse (rs = -.28, p < .001) and lower total HD precaution
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use, this variable was considered a covariate in further analysis. Table 11 reports the
relationships between HD precaution use and the theoretical predictor variables.
Table 11
Correlations between HD Precaution Use and Knowledge, Perceived Risk, Self Efficacy,
Perceived Barriers, Workplace Safety Climate and Interpersonal Influences

Knowledge
Perceived risk
Self efficacy
Perceived
barriers
Workplace
safety climate
Interpersonal
influences

Excretion
Preparation Administration
Disposal
Total HD
1,2
2
2
2
precautions
precautions
precautions precautions precautions3
N = 32
N = 164
N = 154
N = 120
N = 159
-.19
.10
.13
.06
.12
**
*
.18
.21
.18
.10
.21**
.38*
.38**
.38**
.21*
.40**
-.42*

-.47**

-.47**

-.24**

-.48**

.52**

.37**

.42**

.25**

.43**

.56**

.23**

.21**

.22*

.24**

**
rs = * p < .05
p < .01 (2-tailed)
1
Biological safety cabinet
2Chemotherapy Gloves, double gloves, chemotherapy gowns, eye protection and respirators
3
Precautions for administration and disposal only

Hypothesis 1a: Nurses individual characteristics (higher knowledge, higher
perceived risk of harm from HD exposure, higher self-efficacy for using PPE and fewer
perceived barriers) will be associated with an increased use of HD safe handling
precautions.
Higher chemotherapy exposure knowledge was not significantly associated with
higher total HD precaution use. Higher total HD precaution use was associated with
higher perceived risk of harm from HD exposure (rs = .21, p < .01); higher self efficacy
for using PPE (rs =.40, p <.01); and fewer perceived barriers to using PPE (rs = -.48, p <
.01). These findings partially support hypothesis 1a. See Table 11.
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Hypotheses 1b: Organizational factors (better workplace safety climate and
positive interpersonal influences) will be associated with higher safe handling precaution
use.
Higher total HD precaution use was associated with better workplace safety
climate (rs = .43, p < .01), and positive interpersonal influences (rs = .24, p < .01). These
findings support hypothesis 1b. See Table 11.
Hypothesis 1c: Nurses’ individual characteristics (knowledge, perceived risk of
harm from HD exposure, self efficacy for using PPE, barriers to using PPE) and
organizational factors (workplace safety climate and interpersonal influences) will each
account for significant variance in HD safe handling precaution use. Because
chemotherapy exposure knowledge was not related to total HD precaution use, it was not
included in the regression model. The number of patients per day for whom nurses
personally administered chemotherapy was included as a covariate.
The initial regression equation included patients per day in step one as a covariate,
and perceived risk of harm from HD exposure, self efficacy for using PPE, barriers to
using PPE, workplace safety climate and interpersonal influences in the second step.
Only two variables (patients per day and workplace safety climate) were significant, with
barriers having a larger β than workplace safety climate without being significant (p =
.056). A more parsimonious model including only the significant variables was used. The
number of patients per day for whom nurses personally administered chemotherapy,
barriers to PPE use and workplace safety climate were significant (R2 = .29, F(2, 155) =
24.6, p < .001). In the final model, fewer patients per day, fewer barriers to using PPE
and better workplace safety climate were associated with higher total HD precaution use,
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explaining 29% of the variance. Table 12 has the results of the hierarchical regression.
Hypothesis 1c is partially supported.
Table 12
Summary of Hierarchical Regression Analysis for the Variables Predicting Use of
Hazardous Drug Safe Handling Precautions (N = 159)
B

SE

β

t

p-value

Step 1
Constant

2.29 .139

16.5

.000

Patients per Day

-.05 .016 -.24 -3.09

.002

Constant

1.20

1.26

.209

Patients per Day

-.03 .015 -.16 -2.23

.027

Barriers

-.05 .015 -.28 -3.06

.003

Step 2
.96

Workplace Safety Climate .02 .008 .25 2.80
.006
2
Note R = .06 for Step 1, p = .002; ∆R = .23 for Step 2, p <.001
2

Research question 1d: Does nurses’ perceived conflict of interest (need to protect
self vs. need to provide medical care) moderate the relationship between self efficacy and
safe handling precaution use?
Hierarchical regression was performed with Patients per day as a covariate in the
first step, barriers to using PPE, patients per day, workplace safety climate, self efficacy
for using PPE, and conflict of interest in the second step, and an interaction term between
self efficacy for using PPE and conflict of interest in the third step. There was no change
in R2 following the addition of the interaction between self efficacy and conflict of
interest. Therefore, conflict of interest did not moderate the relationship between selfefficacy and total HD precaution use.
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Research Questions about Nurse Managers’ Perceptions of Safe Handling
Precautions
Research Question 2a: What are nurse managers’ perceptions of the
organizational climate for safe handling precautions?
Research Question 2b: For nurses they supervise, what are nurse managers’
perceptions of nurses’ use of safe handling precautions?
Written policies regarding HD safe handling precautions were present in 100% of
workplace settings, according to the managers. All policies addressed the following
aspects of chemotherapy handling: required qualifications of personnel for chemotherapy
handling; required personal protective equipment for chemotherapy handling; procedures
for chemotherapy disposal; procedures for transporting chemotherapy; and procedures for
HD spill management. Two aspects of HD handling were not always addressed in policy.
Sixteen (80%) organizations had policies that address acute exposure management, and
only nine (45%) addressed health monitoring of personnel who handle HDs. Policies
developed by multidisciplinary committees included all recommended elements. Policies
addressed exposure management and health monitoring in organizations where safety
officers and employee health professionals were included in policy development and
review.
All managers reported that there were existing written policies that addressed PPE
use in their organization; however, five of 20 organizations did not require staff to wear
gowns during HD handling. One manager reported that gown use was not required by
OSHA guidelines, when in fact gowns have been recommended by OSHA since 1986.
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Most orientation programs for chemotherapy handling included classroom
education and supervised practice with a preceptor. Sixty percent of managers reported
using a skill checklist during orientation that included HD precautions. Five (25%) of 20
practice settings had a formal mechanism in place for ongoing monitoring of nurses’
compliance with safe handling policies; ten reported using informal “spot checks” to
monitor nurses’ use of HD precautions; and five sites (25%) had nothing in place to
monitor nurses’ safe handling precaution use.
When the managers were asked why the nurses they supervised might not wear
gowns or gloves for HD handling, three managers reported that there was good
compliance with PPE in their setting. Other managers cited the following reasons for
nurses not wearing PPE: gowns not provided by employer (5); too busy or rushed (5);
gowns uncomfortable or cumbersome (4); lack of concern for exposure (4); urgent patient
situations (3); lack of knowledge (3); forgetting (3); poor fitting gloves (1); concern for
cost containment (1); patients’ objections (1); and precautions “too extreme” (1).
One manager stated emphatically that patients object to nurses wearing gowns,
because they do not understand why nurses are “afraid of a drop” of chemotherapy.
Another stated that “there’s noncompliance if you require gowns.” One manager, who
personally handled chemotherapy, admitted not wearing a gown for years because of
discomfort. Another expressed that recommended precautions are too “extreme” and
should be more realistic.
Managers scored 67-104 (M = 92.7 ± 8.6, (potential score = 21-105; Cronbach’s
alpha = .92) on the WSC questionnaire, indicating a positive workplace safety climate.
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Summary
This chapter presented the results of a cross-sectional, correlational study to
determine the relationships among nurses’ use of HD safe handling precautions and
several predictor variables and managers’ perspectives on the use of safe handling
precautions in the workplace. A description of participants’ characteristics, findings from
the questionnaires and results of hypothesis testing were reported.

CHAPTER V
DISCUSSION AND CONCLUSIONS
Chapter V presents a discussion of the study results and the conclusions regarding
the hypotheses. This chapter concludes with a discussion of the limitations, implications
for practice, theory development and future research.
This study adds to the limited body of knowledge about factors influencing the
use of HD safe handling precautions. Previous studies have focused on the frequency of
HD precaution use and some individual factors that are associated with HD safe handling
precaution use. This study was not the first to study organizational factors influencing
HD safe handling precaution use, but it is only the second to measure their impact on use
of HD handling precautions. In a study over 15 years ago, Valanis and others (1991)
reported that the presence of hospital policies increased HCW’s use of HD safe handling
precautions. The use of HDs has become more widespread with administration in
different settings and for non-oncology indications, such as the autoimmune disorders
rheumatoid arthritis, lupus nephritis, and multiple sclerosis, increasing the importance of
promoting the use of safe handling precautions in all settings where HDs are given.
Evaluation of HD Safe Handling Precaution Use
Overall, in this sample of nurses who were knowledgeable about HD use,
experienced in handling chemotherapy, confident in how to use safe handling
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precautions, and who perceived HD exposure to be a risk to their health, use of HD safe
handling precautions was low. Every HD handling activity represents an opportunity for
exposure, and when precautions are not used, the likelihood of exposure increases. The
most frequently used precaution was biological safety cabinets for HD preparation and in
this sample most nurses were not involved in preparing HD for administration. The
second most frequently used precaution was wearing chemotherapy gloves for most
handling activities. Although these precautions are important, they are insufficient to
prevent HD exposure in all situations. As exposure increases, the chance for adverse
health outcomes increases. Currently, few organizations have programs for monitoring
health effects of HD exposure, which was consistent with reports from managers in this
study, making the adverse health effects from HD exposure less likely to be recognized
and documented. This differs from other health threats in the workplace such as hepatitis
B exposure, tuberculosis exposure, and radiation exposure, where health care workers are
monitored regularly. Without data on the exposure to HDs, the full impact of this
exposure may not be realized. Routine medical surveillance of nurses involve in HD
handling activities could provide important data about exposure.
In testing the model relationships, individual nurse characteristics were not
associated with HD safe handling precaution use, whereas organizational characteristics
were. This has important implications since factors in the workplace environment seem
to be the most salient concepts affecting safe handling practices. An unexpected finding
was that a higher number of patients per day per nurse was associated with lower use of
HD safe handling precautions.
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Several authors (Geer et al., 2006; Mahon et al., 1994; Valanis et al., 1991;
Valanis & Shortridge, 1987) have reported that workers cite time pressure or lack of time
as one of the barriers to PPE use across occupational settings. Based on the findings in
this study, that seems to be an accurate assessment. The number of patients assigned to a
nurse in a day, an objective measure of workload, interfered with HD precaution use. The
lack of time was also a reason cited by managers in this study about reasons why nurses
may not use PPE for HD handling in their setting.
Not only has chemotherapy administration moved to outpatient settings over the
last twenty years, but treatment has also migrated away from hospitals to physician
private practices. In this study, nurses working in physician private practice settings cared
for the highest numbers of patients per day—twice that of nurses working in other
settings. It is important to determine the optimal workload for nurses handling
chemotherapy that allows sufficient time for use of safe handling practices. The number
of patients assigned to a nurse each day for administration of HD is a workplace
characteristic over which nurses have little control. Managers of nurses where
chemotherapy is handled must carefully consider workload, not only for safe patient care,
but also to reduce interference with nurses’ use of HD safe handling precautions.
The use of HD safe handling precautions while handling contaminated excreta
was the poorest, with nurses reporting overall use of PPE less than 50% of the time. Since
Universal Precautions (UP) also require barrier precautions for handling blood and body
fluids, this low compliance is difficult to explain. Although most nurses administered and
disposed of HD routinely, the overall use of safe handling precautions was lower for
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administration of HD than for preparation of HD which few nurses were involved in, and
lower still for disposal and handling patient excreta. The low use of HD safe handling
precautions in handling patient excreta may be due to a reduced concern for exposure
because of perceptions about the lower concentration of HDs in body fluids. In
ambulatory settings, it may be that excreta handling is not required as frequently, since
patients are more likely to toilet independently. PPE may not be conveniently located to
facilitate ease of use. Poor use of HD safe handling precautions for handling excreta may
be related to lack of knowledge about drug residue in excreta, but that is unknown in this
sample since the Chemotherapy Exposure Knowledge scale did not measure knowledge
about contaminated excreta. Another possible explanation is that this aspect of HD
handling may not emphasized in education in these settings.
Individual Predictors
Chemotherapy exposure knowledge was not related to use of HD safe handling
precautions. In this study, the lack of relationship between knowledge and the other
theoretical predictor variables is likely due to the lack of variance in this factor. The vast
majority of the nurses answered all of the questions correctly. This indicates that the
knowledge scale used may need to be revised to better discriminate chemotherapy
exposure knowledge levels. However, even with this high knowledge level, HD safe
handling precaution use was poor, indicating that knowledge alone is insufficient to
ensure HD precaution use.
These findings concerning the relationship between knowledge and precaution
use are inconsistent with earlier studies. Ben Ami and colleagues (2001) found that
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failure to comply with HD safe handling precautions was related to lack of education and
Harrison found improved use of precautions following education (Harrison, et al., 1996).
The study samples were obtained from one or two institutions, and one study was set in
Israel. Since both of the previous studies were conducted some time ago, it may be that
HCW knowledge about chemotherapy exposure has improved over the years. The current
study had representation from all regions in the U.S. which is more representative than
several earlier studies about HD use (Mahon et al., 1994; Stajicj et al., 1986; Valanis et
al., 1991).
Although nurses’ perceived risk of harm from HD exposure was related to higher
total HD precaution use, it was not a predictor in the final regression model. Interestingly,
lower perceived risk of harm from HD exposure was associated with more years of
chemotherapy experience. It is unclear if more years of experience was related to a
decreased concern about the occurrence of exposure or a decreased concern about the
potential adverse outcomes of exposure. Lower perceived risk of harm from HD exposure
was associated with lower gown use in a previous study (Martin, 2006). Other authors
(Gershon et al., 1995; Levin, 1999) have reported a positive relationship between
perceived risk and UP use. Those findings were based on simple correlations and not
tested with more advanced statistical tests incorporating multiple variables.
Nurses were more confident about their ability to use HD safe handling
precautions with more years of experience and when their co-workers valued and used
precautions. Self efficacy for using PPE was higher for nurses who reported better
workplace safety climate and fewer barriers to using PPE, but higher self efficacy for
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using PPE was not associated with HD safe handling precaution use in the final model.
Factors in the workplace were more salient for nurses’ use of HD safe handling
precautions. Self efficacy may be a more important concept for behaviors where
individuals have more control over the situation.
Nurses reported lower conflict of interest between protecting self and providing
patient care when their co-workers valued and used precautions and when they worked in
a better workplace safety climate. Nurses who did not perceive a conflict between their
own safety and patient needs reported higher total HD precaution use. In a study of UP
use (Gershon et al., 1995), workers who reported high levels of conflict of interest
between caring for themselves and their patients were half as likely to use UP as those
who reported low conflict levels. This was the first study to measure the effect of conflict
of interest on HD safe handling precaution use, although it’s influence was suggested in
two early studies (Valanis et al., 1991; Valanis & Shortridge, 1987). Although conflict of
interest between self protection and caring for patients did not account for any variance in
HD precaution use in this sample, lower conflict of interest was associated with a better
workplace safety climate, more confidence in using PPE, and fewer barriers. This may
be additional evidence that a strong emphasis on workplace safety may convey that the
health and safety of the nurse (worker) is as important as the patient’s care. Safety
climate and interpersonal influences reflect workplace influences on behavior. The study
findings suggest that actions and attitudes of co-workers and other workplace issues can
influence whether or not nurses experience a conflict between protecting themselves from
HD exposure and providing patient care.
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Organizational Factors
This study is the first to investigate the relationship between workplace safety
climate and HD safe handling precaution use. A better workplace safety climate was
associated with better HD safe handling precaution use by nurses. This finding is similar
to Gershon’s findings in studies of UP compliance in hospitals and other HCW
populations (Gershon et al., 2000; Gershon et al., 2004). Only barriers to using PPE had a
stronger association with HD precaution use.
Initially, it was assumed that nurses in the sample would be responsible for all HD
handling activities except for HD preparation. Previous studies have not always asked
nurses to respond about whether they perform these functions, and thus measured more
general use of safe handling precautions. In this study, precaution use varied with the
handling activity, suggesting that nurses may consider the activities separately when
deciding whether or not to use protective equipment. While NIOSH recommends a
“universal precautions approach” to HD handling (2004, p. 31), this has not happened.
Few nurses in the current study sample prepared chemotherapy, but precaution
use for preparing chemotherapy was better than for other handling activities. Our findings
clearly indicate that precaution use for HD administration, disposal and handling of
contaminated excreta is below recommendations and this must be addressed.
This study included the manager’s perspectives of the organizational safety
climate. Managers reported that their organizations have policies related to HD safe
handling precautions; however, the policies were not always reflective of the scope of the
current OSHA, ONS, ASHP, and NIOSH recommendations. Some managers indicated
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that HD safe handling policies had been developed by an interdisciplinary group, and
those policies addressed all recommended safe handling precautions. Interdisciplinary
safety committees are a characteristic of organizations where worker safety is valued, and
reflects a better workplace safety climate.
Limitations of the Study
The study findings must be considered in the context of some limitations. The
first limitation is related to the representativeness of the sample. The sample size was
adequate to power the study; however, the sample may not be representative of all nurses
handling chemotherapy. Participants were recruited using the ACCC membership list
with the plan to recruit both ONS and non-ONS members. Despite this strategy, 86% of
study respondents reported being ONS members, whereas it is estimated that only 50% of
oncology nurses belong to ONS. While the age and racial diversity of the sample was
similar to that of nurses in the U.S., men were underrepresented. A large number of study
participants were certified in Oncology Nursing, which may make their responses
different from non-oncology certified nurses.
The second limitation relates to the study instruments. Since several of the
questionnaires were adapted for the study, this is the first time they have been used in
nurses responsible for HD handling. The Chemotherapy Exposure Knowledge
questionnaire requires further refinement so that it can distinguish between levels of
knowledge related to the concept. There are no questions related to exposure to
contaminated excrement, for example, since the instrument was originally developed for
chemical exposure in industrial settings where workers do not handle excreta. Low
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knowledge about the potential for HD exposure related to handling excreta may have
helped to interpret the poor HD safe handling precaution use for that handling activity.
The perceived risk scale did not measure some potentially important aspects or risk, such
as immediacy and frequency of adverse outcomes. The conflict of interest scale has only
been used in two studies, and should be tested in larger samples to establish validity and
reliability.
Strengths of the Study
This study had several strengths. First, it used a national sampling frame to
increase representativeness of the sample of oncology nurses handling chemotherapy.
Second, this study was the first to evaluate relationships between organizational factors
and nurses’ use of HD safe handling precautions. Third, no other study to date has
included the managers of nurses who handle HDs. While the sample of managers was
small, the results provide a unique perspective about the impact of workplace safety
climate on nurses’ use of HD safe handling precautions. Finally, this study adds to the
knowledge about nurses’ use of HD safe handling precautions by moving beyond a
descriptive design to a correlational design, which represents an advancement in the
understanding of the phenomenon.
Implications for Practice
As the use of antineoplastic and other HDs increases, more nurses are potentially
exposed as they provide patient care. Based on the study findings, the workplace climate
created by the organization is very important in the routine activities of nurses. This
indicates a very different focus for efforts to improve nurses’ HD precaution use.
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Managers need to be versed in the HD handling safety requirements in order to develop
and support safe handling policies. In this study, not all managers were familiar with
current recommendations for HD safe handling. Some managers minimized the
importance of nurses complying with HD safe handling precautions, and few had a
formal mechanism in place to monitor nurses’ use of PPE.
Current strategies to improve HD precaution use have stressed education to
increase chemotherapy exposure knowledge. Nurses must be knowledgeable about the
potential adverse outcomes from HD exposure and how to prevent exposure. Education is
a necessary component for precaution use, especially for nurses new to chemotherapy
handling. However, even nurses who are knowledgeable and confident in their ability to
use HD safe handling precautions may not always use safe handling precautions without
specific expectations in the work setting. Much of the previous research has focused on
the influence of individual nurse characteristics on whether nurses used safe handling
precautions instead of the influence of the workplace. We know from research in UP that
the workplace has a strong influence (Gershon et al., 2000; Gershon et al., 1999; Gershon
et al., 1995) and this is a fruitful area of inquiry.
Findings from this study indicate that because circumstances in the workplace
interfere with use of precautions, organizational factors must be considered if HD safe
handling precaution use is to improve. Three specific factors—barriers to using PPE,
workplace safety climate and patients per day—are organizational factors that are related
to and likely to have an impact on use of HD safe handling precautions.
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One barrier to HD precaution use is availability of PPE. Nurses cannot use PPE
unless it is available, and providing PPE that is appropriate to a hazard is the employers’
responsibility. Supervisory personnel may be unaware of the need for precautions or may
not support precaution use. Adequate supplies of gowns, gloves, and other protective
equipment must be provided and its use must be encouraged (DeJoy et al., 1995; DeJoy
et al., 2000; Moore et al., 2005).
Encouragement for using PPE is a component of workplace safety climate.
Studies in other populations have reported the definite influence of supervisors providing
positive feedback and reinforcement for safe practices (Dejoy, Gershon et al., 2004;
Grosch, Gershon, Murphy, & DeJoy, 1999; Dov Zohar, 2002). Nurses must not be sent
actual or implied messages to limit PPE use, which is negative reinforcement for
precaution use. Our findings suggest that supervisors’ support for and encouragement of
HD precautions will increase their use.
Budget and staffing may interfere with consistent HD safe handling precaution
use. Since patient care workload impacts nurses’ use of precautions, the number of
patients assigned to a nurse is an important consideration. This may create a conflict for
organizations, since staffing ratios have an economic impact on the organization. Nurses
caring for patients receiving chemotherapy should not be too busy to take time to protect
themselves from HD exposure. This study provides evidence for the influence of nursepatient ratio on nurse safety.
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Implications for Theory Building
Based on these study findings, the model components are insufficient to explain
HD safe handling precaution use. In this study, nurses’ individual characteristics were not
associated with HD safe handling practices, as proposed in the PHDP model. It may be
that the individual nurse characteristics have an indirect relationship with HD safe
handling precaution use, but this was not evaluated. Future research with larger samples,
using more sophisticated statistical analysis such as structural equation modeling may be
helpful in elucidating relationships.
This model was adapted from one used to explain workers’ use of hearing
protection. There are differences in that use of hearing protection devices requires only
the insertion of ear plugs or the use of ear muffs. Use of HD safe handling precautions is
more complicated in that it requires selecting several pieces of protective equipment from
among different types designated for different purposes (e.g. blood and body fluids
precautions or HD protection). Eye and respiratory protection are cumbersome and
uncomfortable. Additionally, HD precaution use occurs in the context of caring for
patients, so is not a fully independent activity. These may be reasons why the influencing
factors differ with the specific type of self-protective behavior.
Further study in larger samples may identify additional variables and
relationships. Different theories related to motivation or theories of organizational
behavior may be more useful in addressing HD safe handling practices.
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Implications for Research
The findings of this study suggest several suggestions for future investigation.
First, this study should be replicated using a larger, more representative sample of
chemotherapy nurses. Little is known about HD precaution use among non-ONS
members, since most studies have not included these nurses. It remains an unanswered
question.
Secondly, additional research is needed to discover other factors that are relevant
to HD precaution use, since the factors in PHDP model were inadequate. Continued
model development using path analysis and structural equation modeling may refine the
relationships among the predictors.
Since fewer barriers to using HD safe handling precautions were a strong
predictor of safe handling precaution use, future research should address ways of
reducing barriers. Some identified barriers that interfere with HD precaution use are
related to the discomfort of wearing PPE are difficult to overcome; however, involving
staff members in the evaluation and selection of PPE may be one effective strategy.
Managers of nurses who handle HDs are an appropriate population for further
study, since they can have a strong influence on nursing practice in their setting. The
impact of positive reinforcement of HD safe handling precaution use by supervisors
should be evaluated. This type of intervention has not been studied in HD safe handling,
and may provide useful information. In addition, managers may identify opportunities for
improvement in PPE use by implementing systematic methods of evaluation of HD safe
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handling precautions that includes checklists as well as random observations of nurses’
practice on their units.
Conflict of interest is a concept unique to HCWs that has not been fully explored.
Two early studies suggested that conflict of interest may interfere with HD safe handling
precaution use (Valanis et al., 1991; Valanis & Shortridge, 1987). The managers in this
study listed “urgent patient situation” and “patient objections” as reasons nurses may not
use PPE, which are indications that the concept is relevant in this population. Its effects
on precaution use should be further studied in oncology nursing. The scale that was used
in this study to measure the concept requires additional development.
Finally, since HD precaution use other than gloves is below current
recommendations, it is essential to evaluate both the occurrence of exposure and its
biological effects. There is currently no registry of data connecting nurses’ exposure
history and health outcomes. A longitudinal, epidemiological study of oncology nurses,
comparing HD-exposed and unexposed nurses, is essential to quantify the occurrence of
adverse effects from HD exposure. Studies that include objective measures of HD
exposure, for example using urine samples, may be helpful in identifying the extent of
exposure. New methods of evaluating the biological consequences of occupational
exposure to HDs are essential.
Conclusions
This study adds to the body of literature regarding oncology nurses’ use of HD
safe handling precautions. Nurses have often been held entirely responsible for their own
practice, including the use of HD safe handling precautions. These study findings
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emphasize the influence that organizations have on nurse’s adoption of self-protective
behaviors; it is clear that safe practice is a shared responsibility between employers and
nurses.
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When the study is completed, a Study Closure Report must be submitted to
the IRB.

2.

For any research that is conducted beyond the one-year approval period, you
must submit a Renewal Application 30 days prior to the approval period
expiration. As a courtesy, an email reminder is sent to the Principal
Investigator approximately two months prior to the expiration of the study.
However, failure to receive an email reminder does not negate your
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Thank you for agreeing to participate in this study of nurses who handle chemotherapy.
“Handling” refers to chemotherapy preparation, administration, disposal, and coming into
contact with patient’s excreta that may be contaminated with chemotherapy.
•
•
•
•

By preparation, we mean transferring chemotherapy drugs from vials or ampoules to
syringes or IV containers.
By administration, we mean giving chemotherapy to patients by IV, injection, orally, etc.
By disposal, we mean discarding equipment used in chemotherapy preparation or
administration.
By handling excreta, we mean emptying bedpans, urinals or emesis basins.

Do you personally handle chemotherapy at work, either chemotherapy preparation or
administration?
Yes
No → If you answered “No” STOP HERE and return the questionnaire.
If you answered “Yes”:
1. Please enter the ID number that is printed on the study
ID Number
letter:
2. Please read each item carefully
3. Place a check in the box next to your selection from the list of options
4. Please answer all of the questions that apply to your chemotherapy handling.
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Section 1
Select one answer to each of the following statements about chemotherapy exposure.
True

1. Chemotherapy can enter the body through breathing it in
2. Chemotherapy can enter the body through ingesting it
3. Chemotherapy cannot enter the body through contact with
contaminated surfaces
4. Chemotherapy can enter the body through contact with spills and
splashes
5. Chemotherapy gas and vapor in air can enter the body through
skin and mucous membranes
6. Oral forms of chemotherapy do not have the potential to be
absorbed
7. Chemotherapy in liquid form can be absorbed through the skin
8. A surgical mask provides protection from chemotherapy aerosols
9. All types of gloves provide the same level of protection
10. Chemotherapy can more easily enter the body through damaged
skin
11. Alcohol hand sanitizer is as effective as soap and water in
removing chemotherapy residue
12. Chemotherapy can enter the body through contaminated foods,
beverages, or cosmetics

False

Don’t
Know
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Section 2
Indicate your level of agreement with each of these statements about using personal protective
equipment (PPE) when handling chemotherapy.
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree:
SA A D SD
1. I am confident that I can use PPE properly
2. I am confident that I can protect myself from chemotherapy exposure
3. I am given enough information on how to protect myself from
chemotherapy exposure
4. My supervisor goes out of his/her way to make sure I am protected
5. Reuse of disposable PPE makes me feel less protected
6. I am provided with the best available PPE
7. My supervisor goes out of his/her way to make sure I am provided
with proper fitting PPE

Section 3
Does your workplace have written policies and/or procedures for handling chemotherapy?
Yes
No
Where is chemotherapy prepared in your workplace?
Pharmacy
Drugs are delivered to the infusion area (prepared in an off-site
location)
Specially designated room separate from the patient care area
Area within the patient treatment area / room
Other (specify)

________________________

What personal protective equipment is available for performing the following
chemotherapy handling activities? Check all that apply.
Gloves
Gowns
Eye
Protection
Preparation
Administration
Handling Excreta
Disposal
Cleaning Spills

Respirator/
Mask
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Section 4

Chemotherapy Preparation:

Are you responsible for preparing chemotherapy?
Yes
No → If you answered “No” proceed to Section 5.
Complete this section ONLY if you prepare chemotherapy drugs.
What type of gloves do you wear while preparing chemotherapy?
None
Chemotherapy designated gloves
Vinyl (polyvinyl chloride, PVC)
Latex examination gloves
Sterile surgical gloves
Other (specify) ____________________
What type of protective clothing do you wear while preparing chemotherapy?
(Check all that apply.)
None
Chemotherapy-designated gown
Personal lab coat
Lab coat provided by office
Cloth gown
Isolation gown
Other (specify) _____________________
Please indicate how much of the time you use the following while preparing chemotherapy:
Always

Biological Safety Cabinet
Closed system transfer device
Gloves labeled for use with chemotherapy
Other gloves (e.g. vinyl)
Double gloves
Gowns labeled for use with chemotherapy
Other gowns (e.g. cloth)
Do you re-use disposable gowns?
Eye protection
Respirator/mask

76-99%

51-75%

26-50%

1-25%

Never
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Section 5

Chemotherapy Administration:

Are you responsible for administering chemotherapy?
No → If you answered “No” proceed to Section 6.

Yes

Complete this section ONLY if you administer chemotherapy.
What type of gloves do you wear while administering chemotherapy?
None
Chemotherapy designated gloves
Vinyl (polyvinyl chloride, PVC)
Latex examination gloves
Sterile surgical gloves
Other (specify) ____________________
What type of protective clothing do you wear while administering chemotherapy?
Check all that apply.
None
Chemotherapy-designated gown
Personal lab coat
Lab coat provided by office
Cloth gown
Isolation gown
Other (specify) _____________________
Please indicate how much of the time you use the following while administering chemotherapy
Always

Closed system transfer device
Gloves labeled for use with chemotherapy
Other gloves (e.g. vinyl)
Double gloves
Gowns labeled for use with chemotherapy
Other gowns (e.g. isolation)
Do you re-use disposable gowns?
Eye protection
Respirator/mask

76-99%

51-75%

26-50%

1-25%

Never
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Section 6

Chemotherapy Disposal:

Are you responsible for disposing of chemotherapy?
Yes
No → If you answered “No” proceed to Section 7.
Complete this section ONLY if you dispose of chemotherapy.
Please indicate how much of the time you use the following when disposing of chemotherapy:
Always

76-99%

51-75%

26-50%

1-25%

Never

Gloves labeled for use with chemotherapy
Other gloves (e.g. vinyl)
Double gloves
Gowns labeled for use with chemotherapy
Other gowns (e.g. isolation)
Do you re-use disposable gowns?
Eye protection
Respirator/mask

Section 7

Handling Contaminated Excreta:

Are you responsible for handling chemotherapy-contaminated excreta?
Yes
No → If you answered “No” proceed to Section 8.
Complete this section ONLY if you handle chemotherapy-contaminated excreta.
Please indicate how much of the time you use the following when handling excreta:
Always

76-99%

51-75%

26-50%

1-25%

Never

Gloves labeled for use with chemotherapy
Other gloves (e.g. vinyl)
Double gloves
Gowns labeled for use with chemotherapy
Other gowns (e.g. isolation)
Do you re-use disposable gowns?
Eye protection
Respirator/mask
Section 8
Are chemotherapy spill kits available in your work area?
Yes
No
During the most recent chemotherapy spill in your workplace,
No
Yes
did you use the materials in the spill kit?
Please write the name of three chemotherapy drugs that you handle most frequently:
___________________________________________
___________________________________________
___________________________________________

N/A
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Section 9
Indicate your level of agreement with each of the following statements.
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree:
SA A D SD
Some reasons that I may not wear PPE regularly when
handling chemotherapy are:
1. I don’t think PPE is necessary
2. I don’t think PPE works
3. I don’t have the time to use PPE
4. I was not trained to use PPE
5. PPE is uncomfortable to wear
6. PPE makes it harder to get the job done
7. PPE is not always available
8. Others around me don’t use PPE
9. There is no policy requiring PPE
10. People would think I am overly cautious
11. It is hard to get chemotherapy-designated PPE
12. PPE is too expensive to use it all the time
13. PPE makes me feel too hot

Section 10
Indicate your level of agreement with each of the following statements about the risks of
chemotherapy exposure.
SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree:
SA A D SD
1. Exposure to chemotherapy is a serious problem at work
2. I am concerned about chemotherapy exposure at work and how it
might affect my health
3. Compared to co-workers, my chance of harm from chemotherapy
exposure is lower
4. If exposed to chemotherapy, there is a real chance that I might
experience bad effects
5. Chemotherapy exposure is not as harmful as some people claim
6. Compared to other work-related health risks, chemotherapy exposure
is less serious
7. I am not worried about future negative health effects from
chemotherapy exposure
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Section 11
How often do the following people wear personal protective equipment when handling
chemotherapy?
About
Does not
Never Sometimes
Usually
Half
apply
Your co-workers
Other nurses you know
Oncology nurses in general
According to the following people, how important is wearing PPE when handling
chemotherapy?
Not at all
Sort Of
Very
Does not
important important important
apply
Your co-workers
Other nurses you know
Your supervisor or manager
Your employer

Section 12
Indicate your level of agreement with each of the following statements.

1.
2.
3.
4.
5.
6.

SA = Strongly Agree; A = Agree; D = Disagree; SD = Strongly Disagree:
SA A D SD
Personal protective equipment keeps me from doing my job to the
best of my abilities.
Wearing personal protective equipment makes my patients worry.
Patient care often interferes with my being able to comply with using
precautions.
I cannot always use safe handling precautions because patient’s
needs come first.
Sometimes I have to choose between wearing PPE and caring for my
patients
Wearing personal protective equipment makes my patients feel
uncomfortable.
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Section 13
Indicate your level of agreement with these statements regarding safety in your work place:
SA = Strongly Agree; A = Agree; N = Neutral; D = Disagree; SD = Strongly Disagree:
SA A N D SD
1. Chemotherapy gloves are readily accessible in my work area
2. Chemotherapy gowns are readily available in my work area
3. The protection of workers from occupational exposure to
chemotherapy is a high priority with management where I work
4. On my unit, all reasonable steps are taken to minimize hazardous
job tasks
5. Employees are encouraged to become involved in safety and
health matters
6. Managers on my unit do their part to insure employees’
protection from occupational exposure to chemotherapy
7. My job duties do not often interfere with my being able to
follow chemotherapy safe handling precautions
8. I have enough time in my work to always follow chemotherapy
safe handling precautions
9. I usually do not have too much to do so that I can follow
chemotherapy safe handling precautions
10. On my unit, unsafe work practices are corrected by supervisors
11. My supervisor talks to me about safe work practices
12. I have had the opportunity to be properly trained to use personal
protective equipment so that I can protect myself from
chemotherapy exposures
13. Employees are taught to be aware of and to recognize potential
health hazards at work
14. In my work area, I have access to policies and procedures
regarding safety
15. My work area is kept clean
16. My work area is not cluttered
17. My work area is not crowded
18. There is minimal conflict within my work area
19. The members of my work area support one another
20. In my work area, there is open communication between
supervisors and staff
21. In my work area we are expected to comply with safe handling
policies and procedures
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Section 14
In what type of setting you do handle chemotherapy?
Inpatient
Outpatient
Please indicate the type of facility you work in:

Both

Academic health center

Private physician office

Community non-teaching hospital

Public/Government hospital

Community teaching hospital

Home care

Health Maintenance organization
Other _________________________
Please indicate the primary state in which you work: ____________________
Male

What is your gender?

Female

What is your RACE or ETHNIC IDENTITY?
American Indian/Alaskan Native

Hispanic/ Latino

Two or more

Asian

Native Hawaiian

Other

Black/African American
White
What is your highest level of NURSING education?
Diploma

Bachelor’s degree

Doctoral Degree

Associate degree
Masters degree
Are you a member of the Oncology Nursing Society?
Yes
No
Are you certified in nursing?
Not certified

AOCN®

NP

OCN®
AOCNS®
AOCNP®
Please enter the number requested:
Your age in years:
Years of nursing experience:
Years of oncology nursing experience:
Years of chemotherapy handling experience:
Number of patients for whom you personally
prepare and/or administer chemotherapy per day
Number of patients receiving chemotherapy per
day at your work place:

Other _______________
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Nurses’ Use of Chemotherapy Safe Handling Precautions
Interview Guide for Managers
Introduce yourself as follows:
My name is __________. I am a research assistant at Georgia State University. I am
calling you for an interview about nurses’ who handle chemotherapy in your
workplace.
Did you receive the consent form? (If no, ask for a fax number so that you can send a
copy of the consent form and reschedule the interview.)
Do you have any questions about the information in the consent form?
START RECORDING. DO NOT USE THE PARTICIPANT’S NAME DURING THE
RECORDING.
Do you agree to be interviewed for this study? This interview will be audio recorded. Do
you agree to have the interview recorded? By answering questions in this
telephone interview you are indicating your consent to participate in this research.
You need not return the consent form to us; the consent form is for your records.
1. Do you manage or supervise nurses who handle chemotherapy, including
preparation, administration, disposal or handling of contaminated excreta?
If answer is no, say: We want to interview people who manage or supervise
nurses who handle chemotherapy. Thank you for your interest in this research.
(End the interview.)
If answer is yes, continue with question 2.
2. What is your title? (The official title for the position you hold at work—manager,
supervisor, director. Write this down reference later.)
_________________________________________________________________
3. Have you personally handled chemotherapy, including preparation,
administration, disposal or handling contaminated excreta in the past year?
(If asked for clarification: By chemotherapy preparation I mean transferring
chemotherapy drugs from vials or ampoules to syringes or IV container.
By administration, I mean giving chemotherapy to patients by IV, injection, or other
route. By handling excreta, I mean activities like emptying bedpans, urinals or
emesis basins).
If answer is yes, ask: Is this a regular part of your responsibility as
(title) _________________________________
How frequently do you personally handle chemotherapy?
(Such as: Daily, weekly, occasionally)
If answer is no, go on to the next question.
4. Do the nurses that you supervise prepare or mix chemotherapy? By chemotherapy
preparation I mean transferring chemotherapy drugs from vials or ampoules to
syringes or IV container. (If no, ask who prepares chemotherapy in their
workplace.)
Nurses’ Use of HD Safe Handling Precautions
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5. Do the nurses that you supervise administer chemotherapy? By administration, I
mean giving chemotherapy to patients by IV, injection, or other route.
6. Do the nurses that you supervise handle contaminated excreta of patients who
receive chemotherapy? By handling excreta, I mean activities like emptying
bedpans, urinals or emesis basins.
7. Tell me about the policies regarding safe handling of chemotherapy in your
workplace. [Such as, are they written or unwritten? Who wrote them? Who was
involved in decisions about safe handling policies? Are the policies the same for
everyone in the workplace such as pharmacy, if applicable? Are the policies
readily available to the nurses? What aspects of chemotherapy handling are
addressed in the policies? (Ask about these if they do not mention them). Does
your policy specifically address:
who may give chemotherapy
what personal protective equipment is required when handling chemotherapy
disposal
transporting chemotherapy
spill cleanup
exposure management
health monitoring of employees
8. How do you ensure that the policies regarding safe handling of chemotherapy are
complied with? (Such as planned, formal evaluation of practice? Informal “spot
checks.”Ask for a description).
9. How often are policies regarding safe handling reviewed and updated?
10. Tell me about the training and orientation that a new nurse receives in your
workplace before handling chemotherapy. (Formal, informal; who conducts; how
long is it. Does it include safe handling precautions?)
11. How do you evaluate nurses’ knowledge and performance of safe handling
precautions? (formal, informal; who conducts and how; how often?)
12. I want you to answer the following questions about your workplace the way that
you think the nurses you supervise would answer them.
(Verbal administration of the Safety Climate Questionnaire follows.)
13. If nurses do not wear gloves or gowns when preparing or administering
chemotherapy, why do you think that is? (If they do not, have you ever asked the
nurses why?
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14. Do you think that chemotherapy exposure is a problem in your work site? (Why
or why not?)
15. The following questions are about your work site. What kind of organization do
you work in?
Inpatient
Outpatient
Both
Academic health center
Community non-teaching hospital
Community teaching hospital
Health maintenance organization
Private physician office
Public/ Government hospital
Home Care
Other (please describe)
16. Please indicate the primary state in which you work:
17. Your Gender

Female

Male

18. Are you a nurse?

Yes

No

19. Your age in years:
20. Number of years in your current position:
21. Number of years of nursing experience:
22. How many employees do you supervise?
23. Number of patients treated /day at your worksite
24. Is there anything else you would like to tell me about safe handling precautions in your
workplace?

Thank you very much for participating in this study. When we contacted you originally,
we sent you one questionnaire for a nurse in your workplace to complete. Are you willing
to give a questionnaire to another nurse in your workplace who handles chemotherapy?

If NO—Thank you. [End recording]. We really appreciate your willingness to participate
in this study. The information you have shared with us will help us understand managers’
perspectives on the use of chemotherapy safe handling precautions. We will use the
results to help improve safety for oncology nurses. [End interview].
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IF YES: Thank you. We will send another nurse questionnaire to you at the same
address we used to contact you for the study. Is that OK? [End recording] (Or, please tell
us where to send the questionnaire and write down the address). [Do not audio-record the
address].

We really appreciate your willingness to participate in this study. The information you
have shared with us will help us understand managers’ perspectives on the use of
chemotherapy safe handling precautions. We will use the results to help improve safety
for oncology nurses. [End interview].
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